Free access
Research Article
1 April 2001

Leptospirosis

SUMMARY

Leptospirosis is a worldwide zoonotic infection with a much greater incidence in tropical regions and has now been identified as one of the emerging infectious diseases. The epidemiology of leptospirosis has been modified by changes in animal husbandry, climate, and human behavior. Resurgent interest in leptospirosis has resulted from large outbreaks that have received significant publicity. The development of simpler, rapid assays for diagnosis has been based largely on the recognition that early initiation of antibiotic therapy is important in acute disease but also on the need for assays which can be used more widely. In this review, the complex taxonomy of leptospires, previously based on serology and recently modified by a genotypic classification, is discussed, and the clinical and epidemiological value of molecular diagnosis and typing is also evaluated.
Leptospirosis is now identified as one of the emerging infectious diseases, exemplified by recent large outbreaks in Nicaragua (78, 100, 349, 507, 581), Brazil, India (645), southeast Asia, the United States (98, 102), and most recently in several countries as a result of the EcoChallenge Sabah 2000 competition in Malaysia (99, 126, 204). In the landmark Institute of Medicine report “Emerging Infections: Microbial Threats to Health in the United States,” leptospirosis was used as an example of an infection which had in the past caused significant morbidity in military personnel deployed in tropical areas (340).
Much of the resurgent international interest in leptospirosis stems from several large clusters of cases which have occurred in Central and South America following flooding as a result of El Niño-related excess rainfall (201, 332, 436, 581, 664). However, the occurrence of large outbreaks of leptospirosis following severe floods is not a new phenomenon and is not restricted to tropical regions (226, 232, 425, 442, 526, 590).
In this review, the epidemiology and clinical features of leptospirosis are described, recent taxonomic changes affecting the genusLeptospira are discussed, and advances in the diagnosis of leptospirosis by serological and molecular methods are analyzed.

HISTORICAL ASPECTS

Leptospirosis is a zoonosis of ubiquitous distribution, caused by infection with pathogenic Leptospira species. The spectrum of human disease caused by leptospires is extremely wide, ranging from subclinical infection to a severe syndrome of multiorgan infection with high mortality. This syndrome, icteric leptospirosis with renal failure, was first reported over 100 years ago by Adolf Weil in Heidelberg (624). However, an apparently identical syndrome occurring in sewer workers was described several years earlier (337, 338). Earlier descriptions of diseases that were probably leptospirosis were reviewed recently (207, 211). Leptospirosis was certainly recognized as an occupational hazard of rice harvesting in ancient China (211), and the Japanese name akiyami, or autumn fever, persists in modern medicine. With hindsight, clear descriptions of leptospiral jaundice can be recognized as having appeared earlier in the 19th century, some years before the description by Weil (211). It has been suggested thatLeptospira interrogans serovar icterohaemorrhagiae was introduced to western Europe in the 18th century by westward extension of the range of of Rattus norvegicus from Eurasia (24).
The etiology of leptospirosis was demonstrated independently in 1915 in Japan and Germany (207). In Japan, Inada and Ido detected both spirochetes and specific antibodies in the blood of Japanese miners with infectious jaundice, and two groups of German physicians studied German soldiers afflicted by “French disease” in the trenches of northeast France. Uhlenhuth and Fromme (588) and Hubener and Reiter (289) detected spirochetes in the blood of guinea pigs inoculated with the blood of infected soldiers. Unfortunately, these two groups became so embroiled in arguments over priority that they overlooked the first publications in English (296) and German of papers by Inada's group, whose initial publications predated their own by 8 months (207). Confirmation of the occurrence of leptospirosis on both sides of the Western Front was obtained rapidly after the publication in Europe of Inada's work (131, 145, 543, 630).
Given the initial controversy over nomenclature, it is ironic that the organism had first been described almost 10 years before (542). Stimson demonstrated by silver staining the presence of clumps of spirochetes in the kidney tubules of a patient who reportedly died of yellow fever. The spirochetes had hooked ends, and Stimson named them Spirochaeta interrogans because of their resemblance to a question mark. Unfortunately, this sentinel observation was overlooked for many years (211).
The importance of occupation as a risk factor was recognized early. The role of the rat as a source of human infection was discovered in 1917 (293), while the potential for leptospiral disease in dogs was recognized, but clear distinction between canine infection withL. interrogans serovars icterohaemorrhagiae and canicola took several years (329). Leptospirosis in livestock was recognized some years later (24). Several monographs provide extensive information on the early development of knowledge on leptospirosis (24, 211, 213, 596, 634).

BACTERIOLOGY

Taxonomy and Classification

Serological classification.

Prior to 1989, the genusLeptospira was divided into two species, L. interrogans, comprising all pathogenic strains, and L. biflexa, containing the saprophytic strains isolated from the environment (217, 309). L. biflexa was differentiated from L. interrogans by the growth of the former at 13°C and growth in the presence of 8-azaguanine (225 μg/ml) and by the failure of L. biflexa to form spherical cells in 1 M NaCl.
Both L. interrogans and L. biflexa are divided into numerous serovars defined by agglutination after cross-absorption with homologous antigen (162, 309, 330). If more than 10% of the homologous titer remains in at least one of the two antisera on repeated testing, two strains are said to belong to different serovars (297). Over 60 serovars of L. biflexa have been recorded (309). Within the species L. interrogans over 200 serovars are recognized; additional serovars have been isolated but have yet to be validly published. Serovars that are antigenically related have traditionally been grouped into serogroups (330). While serogroups have no taxonomic standing, they have proved useful for epidemiological understanding. The serogroups of L. interrogans and some common serovars are shown in Table 1.
Table 1.
Table 1. Serogroups and some serovars of L. interrogans sensu lato
Serogroup Serovar(s)
icterohaemorrhagiae, Icterohaemorrhagiae, copenhageni, lai, zimbabwe
Hebdomadis hebdomadis, jules, kremastos
Autumnalis autumnalis, fortbragg, bim, weerasinghe
Pyrogenes pyrogenes
Bataviae bataviae
Grippotyphosa grippotyphosa, canalzonae, ratnapura
Canicola canicola
Australis australis, bratislava, lora
Pomona pomona
Javanica javanica
Sejroe sejroe, saxkoebing, hardjo
Panama panama, mangus
Cynopteri cynopteri
Djasiman djasiman
Sarmin sarmin
Mini mini, georgia
Tarassovi tarassovi
Ballum ballum, aroborea
Celledoni celledoni
Louisiana louisiana, lanka
Ranarum ranarum
Manhao manhao
Shermani shermani
Hurstbridge hurstbridge

Genotypic classification.

The phenotypic classification of leptospires has been replaced by a genotypic one, in which a number of genomospecies include all serovars of both L. interrogansand L. biflexa. Genetic heterogeneity was demonstrated some time ago (80, 260), and DNA hybridization studies led to the definition of 10 genomospecies of Leptospira(658). An additional genomospecies, L. kirschneri, was added later (475). After an extensive study of several hundred strains, workers at the Centers for Disease Control (CDC) more recently defined 16 genomospecies ofLeptospira that included those described previously (475, 658) and adding five new genomospecies (81), one of which was named L. alexanderi. An additional species, L. fainei, has since been described, which contains a new serovar, hurstbridge (450). DNA hybridization studies have also confirmed the taxonomic status of the monospecific genus Leptonema (81, 474). The genotypic classification of leptospires is supported by multilocus enzyme electrophoresis data (348), but recent studies suggest that further taxonomic revisions are likely (348, 462).
The genomospecies of Leptospira do not correspond to the previous two species (L. interrogans and L. biflexa), and indeed, pathogenic and nonpathogenic serovars occur within the same species (Table 2). Thus, neither serogroup nor serovar reliably predicts the species ofLeptospira (Table 3). Moreover, recent studies (81, 222) have included multiple strains of some serovars and demonstrated genetic heterogeneity within serovars (Table 4). In addition, the phenotypic characteristics formerly used to differentiate L. interrogans sensu lato from L. biflexa sensu lato do not differentiate the genomospecies (81, 658).
Table 2.
Table 2. Genomospecies of Leptospira and distribution of serogroupsa
Species Serogroupsb
L. interrogans Icterohaemorrhagiae, Canicola, Pomona, Australis, Autumnalis, Pyrogenes, Grippotyphosa, Djasiman, Hebdomadis, Sejroe, Bataviae, Ranarum, Louisiana, Mini, Sarmin
L. noguchii Panama, Autumnalis, Pyrogenes, Louisiana, Bataviae, Tarassovi, Australis, Shermani, Djasiman, Pomona
L. santarosai Shermani, Hebdomadis, Tarassovi, Pyrogenes, Autumnalis, Bataviae, Mini, Grippotyphosa, Sejroe, Pomona, Javanica, Sarmin, Cynopteri
L. meyeri Ranarum, Semaranga, Sejroe, Mini, Javanica
L. wolbachiic Codice
L. biflexac Semaranga, Andamana
L. fainei Hurstbridge
L. borgpetersenii Javanica, Ballum, Hebdomadis, Sejroe, Tarassovi, Mini, Celledoni, Pyrogenes, Bataviae, Australis, Autumnalis
L. kirschneri Grippotyphosa, Autumnalis, Cynopteri, Hebdomadis, Australis, Pomona, Djasiman, Canicola, Icterohaemorrhagiae, Bataviae,
L. weilii Celledoni, Icterohaemorrhagiae, Sarmin, Javanica, Mini, Tarassovi, Hebdomadis, Pyrogenes, Manhao, Sejroe
L. inadai Lyme, Shermani, Icterohaemorrhagiae, Tarassovi, Manhao, Canicola, Panama, Javanica
L. parvac Turneria
L. alexanderi Manhao, Hebdomadis, Javanica, Mini
a
Based on data reported by Brenner et al. (81) and Perolat et al. (450)
b
Serogroups Semaranga, Andamana, Codice, and Turneria contain nonpathogenic leptospires.
c
Currently only nonpathogenic strains of these species are known.
Table 3.
Table 3. Genomospecies associated with serogroupsa
Serogroup Genomospecies
Andamana L. biflexa
Australis L. interrogans, L. noguchii, L. borgpetersenii, L. kirschneri
Autumnalis L. interrogans, L. noguchii, L. santarosai, L. borgpetersenii, L. kirschneri
Ballum L. borgpetersenii
Bataviae L. interrogans, L. noguchii, L. santarosai, L. borgpetersenii, L. kirschneri
Canicola L. interrogans, L. inadai, L. kirschneri
Celledoni L. weilii, L. borgpetersenii
Codice L. wolbachii
Cynopteri L. santarosai, L. kirschneri
Djasiman L. interrogans, L. noguchii, L. kirschneri
Grippotyphosa L. interrogans, L. santarosai, L. kirschneri
Hebdomadis L. interrogans, L. weilii, L. santarosai, L. borgpetersenii, L. kirschneri, L. alexanderi
Hurstbridge L. fainei
Icterohaemorrhagiae L. interrogans, L. weilii, L. inadai, L. kirschneri
Javanica L. weilii, L. santarosai, L. borgpetersenii, L. meyeri, L. inadai, L. alexanderi
Louisiana L. interrogans, L. noguchii
Lyme L. inadai
Manhao L. weilii, L. inadai, L. alexanderi
Mini L. interrogans, L. weilii, L. santarosai, L. borgpetersenii, L. meyeri, L. alexanderi
Panama L. noguchii, L. inadai
Pomona L. interrogans, L. noguchii, L. santarosai, L. kirschneri
Pyrogenes L. interrogans, L. noguchii, L. weilii, L. santarosai, L. borgpetersenii
Ranarum L. interrogans, L. meyeri
Sarmin L. interrogans, L. weilii, L. santarosai
Sejroe L. interrogans, L. weilii, L. santarosai, L. borgpetersenii, L. meyeri
Semaranga L. meyeri, L. biflexa
Shermani L. noguchii, L. santarosai, L. inadai
Tarassovi L. noguchii, L. weilli, L. santarosai, L. borgpetersenii, L. inadai
a
Based on data reported by Brenner et al. (81) and Perolat et al. (450).
Table 4.
Table 4. Leptospiral serovars found in multiple speciesa
Serovar Species
bataviae L. interrogans, L. santarosai
bulgarica L. interrogans, L. kirschneri
grippotyphosa L. kirschneri, L. interrogans
hardjo L. borgpetersenii, L. interrogans, L.meyeri
icterohaemorrhagiae L. interrogans, L. inadai
kremastos L. interrogans, L. santarosai
mwogolo L. kirschneri, L. interrogans
paidjan L. kirschneri, L. interrogans
pomona L. interrogans, L. noguchii
pyrogenes L. interrogans, L. santarosai
szwajizak L. interrogans, L. santarosai
valbuzzi L. interrogans, L. kirschneri
a
Based on data reported by Brenner et al. (81) and by Feresu et al. (223).
The reclassification of leptospires on genotypic grounds is taxonomically correct and provides a strong foundation for future classifications. However, the molecular classification is problematic for the clinical microbiologist, because it is clearly incompatible with the system of serogroups which has served clinicians and epidemiologists well for many years. Until simpler DNA-based identification methods are developed and validated, it will be necessary for clinical laboratories to retain the serological classification of pathogenic leptospires for the foreseeable future. In addition, the retention of L. interrogans and L. biflexa as specific names in the genomic classification also allows nomenclatural confusion. In the following pages, specific names refer to the genomospecies, including L. interrogans sensu stricto and L. biflexa sensu stricto.

Biology of Leptospires

Leptospires are tightly coiled spirochetes, usually 0.1 μm by 6 to 0.1 by 20 μm, but occasional cultures may contain much longer cells. The helical amplitude is approximately 0.1 to 0.15 μm, and the wavelength is approximately 0.5 μm (213). The cells have pointed ends, either or both of which are usually bent into a distinctive hook (Fig. 1). Two axial filaments (periplasmic flagella) with polar insertions are located in the periplasmic space (550). The structure of the flagellar proteins is complex (583). Leptospires exhibit two distinct forms of movement, translational and nontranslational (60). Morphologically all leptospires are indistinguishable, but the morphology of individual isolates varies with subculture in vitro and can be restored by passage in hamsters (186). Leptospires have a typical double membrane structure in common with other spirochetes, in which the cytoplasmic membrane and peptidoglycan cell wall are closely associated and are overlain by an outer membrane (254). Leptospiral lipopolysaccharide has a composition similar to that of other gram-negative bacteria (603), but has lower endotoxic activity (519). Leptospires may be stained using carbol fuchsin counterstain (211).
Fig. 1.
Fig. 1. Scanning electron micrograph of L. interrogans serovar icterohaemorrhagiae strain RGA bound to a 0.2-μm membrane filter. Reproduced from reference 625awith permission from the publisher.
Leptospires are obligate aerobes with an optimum growth temperature of 28 to 30°C. They produce both catalase and oxidase (530). They grow in simple media enriched with vitamins (vitamins B2 and B12 are growth factors), long-chain fatty acids, and ammonium salts (309). Long-chain fatty acids are utilized as the sole carbon source and are metabolized by β-oxidation (530).

Culture Methods

Growth of leptospires in media containing either serum or albumin plus polysorbate and in protein-free synthetic media has been described (587). Several liquid media containing rabbit serum were described by Fletcher, Korthoff, Noguchi, and Stuart (587); recipes for these earlier media are found in several monographs (24, 213, 548, 634). The most widely used medium in current practice is based on the oleic acid-albumin medium EMJH (184, 310). This medium is available commercially from several manufacturers and contains Tween 80 and bovine serum albumin. Some strains are more fastidious and require the addition of either pyruvate (312) or rabbit serum (196) for initial isolation. Growth of contaminants from clinical specimens can be inhibited by the addition of 5-fluorouracil (311). Other antibiotics have been added to media for culture of veterinary specimens, in which contamination is more likely to occur (8, 413). Protein-free media have been developed for use in vaccine production (64, 504, 518, 541).
Growth of leptospires is often slow on primary isolation, and cultures are retained for up to 13 weeks before being discarded, but pure subcultures in liquid media usually grow within 10 to 14 days. Agar may be added at low concentrations (0.1 to 0.2%). In semisolid media, growth reaches a maximum density in a discrete zone beneath the surface of the medium, which becomes increasingly turbid as incubation proceeds. This growth is related to the optimum oxygen tension (213) and is known as a Dinger's ring or disk (164). Leptospiral cultures may be maintained by repeated subculture (608) or preferably by storage in semisolid agar containing hemoglobin (213). Long-term storage by lyophilization (31) or at −70°C (20, 432) is also used.
Growth on media solidified with agar has been reported (494, 587). Colonial morphology is dependent on agar concentration and serovar (582). Media can also be solidified using gellan gum (496). Solid media have been used for isolation of leptospires (572), to separate mixed cultures of leptospires, and for detection of hemolysin production (539).

Molecular Biology

Leptospires are phylogenetically related to other spirochetes (446). The leptospiral genome is approximately 5,000 kb in size (52, 669), although smaller estimates have been reported (558, 649). The genome is comprised of two sections, a 4,400-kb chromosome and a smaller 350-kb chromosome (669). Other plasmids have not been reported (125, 292). Physical maps have been constructed from serovars pomona subtype kennewicki (669) and icterohaemorrhagiae (74, 552). Leptospires contain two sets of 16S and 23S rRNA genes but only one 5S rRNA gene (230), and the rRNA genes are widely spaced (51, 231).
The study of leptospiral genetics has been slowed by the lack of a transformation system (317, 677). Recently, a shuttle vector was developed using the temperate bacteriophage LE1 fromL. biflexa (498). This advance offers the prospect of more rapid progress in the understanding ofLeptospira at the molecular level.
Several repetitive elements have been identified (73, 317, 553, 641, 673), of which several are insertion sequences (IS) coding for transposases. IS1533 has a single open reading frame (668), while IS1500 has four (73). Both IS1500 and IS1533 are found in many serovars (73, 672), but the copy number varies widely between different serovars and among isolates of the same serovar (74). A role for these insertion sequences in transposition and genomic rearrangements has been identified (73, 74, 668, 677). Other evidence for horizontal transfer within the genus Leptospira has been reported (468).
A number of leptospiral genes have been cloned and analyzed, including several for amino acid synthesis (163, 486, 674), rRNA (228, 229), ribosomal proteins (676), RNA polymerase (483), DNA repair (540), heat shock proteins (47, 441), sphingomyelinase (508, 509), hemolysins (154, 343), outer membrane proteins (168, 255, 256, 515), flagellar proteins (354, 355, 398, 584, 640), and lipopolysaccharide (LPS) synthesis (88, 152, 317, 397).
Within serovar icterohaemorrhagiae, the genome appears to be conserved (281, 552). This conservation allowed the identification of at least one new serovar by recognition of distinct pulsed-field gel electrophoresis (PFGE) profiles (280). However, the recent demonstration of heterogeneity within serovars (81, 222) indicates the need for further study of multiple isolates of individual serovars.

EPIDEMIOLOGY

Leptospirosis is presumed to be the most widespread zoonosis in the world (646). The source of infection in humans is usually either direct or indirect contact with the urine of an infected animal. The incidence is significantly higher in warm-climate countries than in temperate regions (208, 479); this is due mainly to longer survival of leptospires in the environment in warm, humid conditions. However, most tropical countries are also developing countries, and there are greater opportunities for exposure of the human population to infected animals, whether livestock, domestic pets, or wild or feral animals. The disease is seasonal, with peak incidence occurring in summer or fall in temperate regions, where temperature is the limiting factor in survival of leptospires, and during rainy seasons in warm-climate regions, where rapid dessication would otherwise prevent survival.
The reported incidence of leptospirosis reflects the availability of laboratory diagnosis and the clinical index of suspicion as much as the incidence of the disease. Within the United States, the highest incidence is found in Hawaii (101). Leptospirosis ceased to be a notifiable infection within the United States after December 1994 (97).
The usual portal of entry is through abrasions or cuts in the skin or via the conjunctiva; infection may take place via intact skin after prolonged immersion in water, but this usually occurs when abrasions are likely to occur and is thus difficult to substantiate. Water-borne transmission has been documented; point contamination of water supplies has resulted in several outbreaks of leptospirosis (Table5). Inhalation of water or aerosols also may result in infection via the mucous membranes of the respiratory tract. Rarely, infection may follow animal bites (55, 158, 244, 360, 525). Direct transmission between humans has been demonstrated rarely (see Other Complications, below). However, excretion of leptospires in human urine months after recovery has been recorded (46, 307). It is thought that the low pH of human urine limits survival of leptospires after excretion. Transmission by sexual intercourse during convalescence has been reported (167, 262).
Table 5.
Table 5. Documented outbreaks of leptospirosis associated with water
Place and yr No. of cases Exposure Source of infection Presumptive serogroup Reference
Lisbon, Portugal, 1931 126 Drinking from water fountain Contamination by rat urine Unknown 315
Greece, 1931 31 Drinking water in a cafe Contamination by rat urine Unknown 457
Philadelphia, 1939 7 Swimming in a creek Contamination by rat urine Icterohaemorrhagiae; serovar icterohaemorrhagiae isolated from one case 272
Georgia, 1940 35 Swimming in a creek Contamination by offal and a dead cow Unknown 75
Wyoming, 1942 24 Swimming in a pool Unknown Canicola 120
Okinawa, 1949 16 Swimming in a pond Unknown Autumnalis 236
Alabama, 1950 50 Swimming in a creek Suspected to be pigs Pomona 503
Georgia, 1952 26 Swimming in a creek Suspected to be dogs Canicola 628
Russia, 1952 Not stated Swimming in a lake Suspected to be pigs and/or rats Canicola 597
Japan, 1953 114 Swimming in a river Suspected to be dogs Canicola; serovar canicola isolated 396
Russia, 1954 62 Drinking and bathing in well water Contamination by pigs Serovar pomona isolated 68
South Dakota, 1956 3 Swimming in a river Unknown Pomona 304
Florida, 1958 9 Swimming in a stream Contamination by cattle and/or pigs Serovar pomona isolated from pigs 121
Iowa, 1959 40 Swimming in a stream Contamination by cattle Serovar pomona isolated from two cases and from cattle 79
Washington, 1964 61 Swimming in a canal Suspected to be cattle Pomona; serovar pomona isolated from cattle 414
Tennessee, 1975 7 Swimming in a creek Unknown Grippotyphosa 26
Buenos Aires, Argentina, 1976 10 Swimming in a drainage canal Suspected to be pigs Pomona; Pomona serogroup isolated from patients 93
Italy, 1984 35 Drinking from water fountain Dead hedgehog in header tank Australis 92
Missouri, 1985 4 Kayaking in creek during flooding Unknown Djasiman 306
Morón, Cuba, 1986 6 Swimming in a canal Suspected to be dogs Canicola 277
Okinawa, Japan, 1987 22 Swimming in a pool or jungle training Unknown Shermani 130
Kauai, Hawaii, 1987 8 Swimming in a river Suspected to be cattle Australis; serovars bangkok and bataviae isolated 320
São Paulo, Brazil, 1987 23 Swimming in a pool with river water Unknown Pomona 153
Illinois, 1991 5 Swimming in a pond Unknown; several animal species seropositive Grippotyphosa; serovar grippotyphosa isolated from patients and water 302
Kauai, Hawaii, 1992 8 Swimming in a waterfall Unknown Australis; serovar bangkok isolated 321
Costa Rica, 1996 9 White water rafting Unknown Unknown 482
Barbados, 1997 2 Swimming in a pond Unknown Serovar bim isolated from one case 542a
Illinois & Wisconsin, 1998 74 Swimming in a lake Unknown Unknown 98
Animals, including humans, can be divided into maintenance hosts and accidental (incidental) hosts. The disease is maintained in nature by chronic infection of the renal tubules of maintenance hosts (43). A maintenance host is defined as a species in which infection is endemic and is usually transferred from animal to animal by direct contact. Infection is usually acquired at an early age, and the prevalence of chronic excretion in the urine increases with the age of the animal. Other animals (such as humans) may become infected by indirect contact with the maintenance host. Animals may be maintenance hosts of some serovars but incidental hosts of others, infection with which may cause severe or fatal disease. The most important maintenance hosts are small mammals, which may transfer infection to domestic farm animals, dogs, and humans. The extent to which infection is transmitted depends on many factors, including climate, population density, and the degree of contact between maintenance and accidental hosts. Different rodent species may be reservoirs of distinct serovars, but rats are generally maintenance hosts for serovars of the serogroups lcterohaemorrhagiae and Ballum, and mice are the maintenance hosts for serogroup Ballum. Domestic animals are also maintenance hosts; dairy cattle may harbor serovars hardjo, pomona, and grippotyphosa; pigs may harbor pomona, tarassovi, or bratislava; sheep may harbor hardjo and pomona; and dogs may harbor canicola (69). Distinct variations in maintenance hosts and the serovars they carry occur throughout the world (266). A knowledge of the prevalent serovars and their maintenance hosts is essential to understanding the epidemiology of the disease in any region.
Human infections may be acquired through occupational, recreational, or avocational exposures. Occupation is a significant risk factor for humans (609). Direct contact with infected animals accounts for most infections in farmers, veterinarians, abattoir workers (95, 104, 570), meat inspectors (65), rodent control workers (155), and other occupations which require contact with animals (27, 357). Indirect contact is important for sewer workers, miners, soldiers (87, 314, 361), septic tank cleaners, fish farmers (241, 489), gamekeepers, canal workers (29), rice field workers (219, 430, 615), taro farmers (25), banana farmers (535), and sugar cane cutters (132).
Miners were the first occupational risk group to be recognized (86, 296). The occurrence of Weil's disease in sewer workers was first reported in the 1930s (23, 218, 308, 545). Serovar icterohaemorrhagiae was isolated by guinea pig inoculation from patients, from rats trapped in sewers (23, 308), and from the slime lining the sewers (23). In Glasgow, Scotland, a seroprevalence among sewer workers of 17% was reported (545). The recognition of this important risk activity led to the adoption of rodent control programs and the use of protective clothing, resulting in a significant reduction in cases associated with this occupation. The presence in wastewater of detergents is also thought to have reduced the survival of leptospires in sewers (610), since leptospires are inhibited at low detergent concentrations (106).
Fish workers were another occupational group whose risk of contracting leptospirosis was recognized early. Between 1934 and 1948, 86% of all cases in the northeast of Scotland occurred in fish workers in Aberdeen (532). Recognition of risk factors and adoption of both preventive measures and rodent control have reduced the incidence of these occupational infections greatly. From 1933 to 1948 in the British Isles, there were 139 cases in coal miners, 79 in sewer workers, and 216 in fish workers. However, in the period from 1978 to 1983, there were nine cases in these three occupations combined (610). More recently, fish farmers have been shown to be at risk (489), particularly for infection with serovars of serogroup Icterohaemorrhagiae (241), presumed to be derived from rat infestation of premises. Because of the high mortality rate associated with Icterohaemorrhagiae infections, this was considered an important occupational risk group despite the very small absolute number of workers affected (240).
Livestock farming is a major occupational risk factor throughout the world. The highest risk is associated with dairy farming and is associated with serovar hardjo (66, 458, 500, 609), in particular with milking of dairy cattle (263, 352, 528). Human cases can be associated with clinical disease in cattle (263, 500), but are not invariably so (30, 138). Cattle are maintenance hosts of serovar hardjo (192), and infection with this serovar occurs throughout the world (45, 412, 466). Many animals are seronegative carriers (192, 267, 571). After infection, leptospires localize in the kidneys (249, 427, 465, 571, 626) and are excreted intermittently in the urine (189). Serovar hardjo causes outbreaks of mastitis (196) and abortion (190). Serovar hardjo is found in aborted fetuses and in premature calves (188, 194, 238, 268). In addition, hardjo has been isolated from normal fetuses (191), the genital tracts of pregnant cattle (191), vaginal discharge after calving (193), and the genital tract and urinary tract of >50% of cows (197, 198) and bulls (185). In Australia, both serovars hardjo and pomona were demonstrated in bovine abortions, but serological evidence suggested that the incidence of hardjo infection was much higher (182, 305, 529). In Scotland, 42% of cattle were seropositive for hardjo, representing 85% of all seropositive animals (187). In the United States, serovar hardjo is the most commonly isolated serovar in cattle (198), but pomona also occurs.
There is a significant risk associated with recreational exposures occurring in water sports (405), including swimming, canoeing (306, 517), white water rafting (482, 591, 627), fresh water fishing, and other sports where exposure is common, such as potholing and caving (611). The potential for exposure of large numbers of individuals occurs during competitive events (98, 99, 102, 126, 204). Several outbreaks of leptospirosis associated with water have been reported (Table 5). Many of these outbreaks have followed extended periods of hot, dry weather, when pathogenic leptospires presumably have multiplied in freshwater ponds or rivers. Cases of leptospirosis also follow extensive flooding (111, 153, 201, 226, 232, 425, 436, 442, 526, 590, 645).
Pathogenic serovars have been isolated from water in tropical regions (19) and in the United States, where serovars icterohaemorrhagiae, dakota, ballum, pomona, and grippotyphosa have been recovered (137, 161, 242). Survival of pathogenic leptospires in the environment is dependent on several factors, including pH, temperature, and the presence of inhibitory compounds. Most studies have used single serovars and quite different methodologies, but some broad conclusions may be drawn. Under laboratory conditions, leptospires in water at room temperature remain viable for several months at pH 7.2 to 8.0 (106, 246), but in river water survival is shorter and is prolonged at lower temperatures (106, 137). The presence of domestic sewage decreases the survival time to a matter of hours (106), but in an oxidation ditch filled with cattle slurry, viable leptospires were detected for several weeks (160). In acidic soil (pH 6.2) taken from canefields in Australia, serovar australis survived for up to 7 weeks, and in rainwater-flooded soil it survived for at least 3 weeks (531). When soil was contaminated with urine from infected rats or voles, leptospires survived for approximately 2 weeks (319, 531). In slightly different soil, serovar pomona survived for up to 7 weeks under conditions approximating the New Zealand winter (274).
Many sporadic cases of leptospirosis in tropical regions are acquired following avocational exposures that occur during the activities of daily life (205, 454). Many infections result from barefooted walking in damp conditions or gardening with bare hands (170). Dogs are a significant reservoir for human infection in many tropical countries (623) and may be an important source of outbreaks (Table 6). A number of outbreaks of leptospirosis have resulted from contamination of drinking water (Table 5) and from handling rodents (14).
Table 6.
Table 6. Documented outbreaks of leptospirosis associated with dogs
Place and yr No. of cases Source of infection Presumptive serogroup Infecting serovar Reference
North Dakota, 1950 9 Infected family pet dog Canicola Not isolated 271
Texas, 1971 7 Infected pet dogs Canicola canicola 54
Portland, Oreg., 1972 9 Infected family pet dog Autumnalis fortbragg 225
St. Louis, Mo., 1972 5 Infected pet dogs, previously immunized Icterohaemorrhagiae icterohaemorrhagiae 221
Barbados, 1988 1 Infected guard dogs in kennels, immunized Autumnalis bim 206
Three epidemiological patterns of leptospirosis were defined by Faine (211). The first occurs in temperate climates where few serovars are involved and human infection almost invariably occurs by direct contact with infected animals though farming of cattle and pigs. Control by immunization of animals and/or humans is potentially possible. The second occurs in tropical wet areas, within which there are many more serovars infecting humans and animals and larger numbers of reservoir species, including rodents, farm animals, and dogs. Human exposure is not limited by occupation but results more often from the widespread environmental contamination, particularly during the rainy season. Control of rodent populations, drainage of wet areas, and occupational hygiene are all necessary for prevention of human leptospirosis. These are also the areas where large outbreaks of leptospirosis are most likely to occur following floods, hurricanes, or other disasters (111, 158, 201, 226, 232, 425, 436, 442, 526, 590). The third pattern comprises rodent-borne infection in the urban environment. While this is of lesser significance throughout most of the world, it is potentially more important when the urban infrastructure is disrupted by war or by natural disasters. This type of infection is now rarely seen in developed countries (157), but is exemplified by the recent rediscovery of urban leptospirosis in Baltimore (601) and by outbreaks occurring in slum areas in developing countries (332).

CLINICAL FEATURES OF LEPTOSPIROSIS

Leptospirosis has been described as a zoonosis of protean manifestations (456, 644). Indeed, this description has been so overused as to have become a cliché. The spectrum of symptoms is extremely broad; the classical syndrome of Weil's disease represents only the most severe presentation. Formerly it was considered that distinct clinical syndromes were associated with specific serogroups (596). However, this view was questioned by some authorities (18, 180, 220), and more intense study over the past 30 years has refuted this hypothesis. An explanation for many of the observed associations may be found in the ecology of the maintenance animal hosts in a geographic region. A region with a richly varied fauna will support a greater variety of serogroups than will a region with few animal hosts. In humans, severe leptospirosis is frequently but not invariably caused by serovars of the icterohaemorrhagiae serogroup. The specific serovars involved depend largely on the geographic location and the ecology of local maintenance hosts. Thus in Europe, serovars copenhageni and icterohaemorrhagiae, carried by rats, are usually responsible for infectious, while in Southeast Asia, serovar lai is common.
The clinical presentation of leptospirosis is biphasic (Fig.2), with the acute or septicemic phase lasting about a week, followed by the immune phase, characterized by antibody production and excretion of leptospires in the urine (180, 325, 585). Most of the complications of leptospirosis are associated with localization of leptospires within the tissues during the immune phase and thus occur during the second week of the illness.
Fig. 2.
Fig. 2. Biphasic nature of leptospirosis and relevant investigations at different stages of disease. Specimens 1 and 2 for serology are acute-phase specimens, 3 is a convalescent-phase sample which may facilitate detection of a delayed immune response, and 4 and 5 are follow-up samples which can provide epidemiological information, such as the presumptive infecting serogroup. (Adapted from reference586a with permission of the publisher.)

Anicteric Leptospirosis

The great majority of infections caused by leptospires are either subclinical or of very mild severity, and patients will probably not seek medical attention. A smaller proportion of infections, but the overwhelming majority of the recognized cases, present with a febrile illness of sudden onset. Other symptoms include chills, headache, myalgia, abdominal pain, conjunctival suffusion, and less often a skin rash (Table 7). If present, the rash is often transient, lasting less than 24 h. This anicteric syndrome usually lasts for about a week, and its resolution coincides with the appearance of antibodies. The fever may be biphasic and may recur after a remission of 3 to 4 days. The headache is often severe, resembling that occurring in dengue, with retro-orbital pain and photophobia. Myalgia affecting the lower back, thighs, and calves is often intense (18, 325).
Table 7.
Table 7. Signs and symptoms on admission in patients with leptospirosis in large case series
Symptom % of patients
China, 1955 (115), n = 75 Puerto Rico, 1963 (18), n = 208 China, 1965 (615), n = 168 Vietnam, 1973 (61) n = 150 Korea, 1987 (442), n = 93 Barbados, 1990 (177), n = 88 Seychelles, 1998 (660), n = 75 Brazil, 1999 (332), n = 193
Jaundice 72 49 0 1.5 16 95 27 93
Anorexia 92 a 46 80 85
Headache 88.5 91 90 98 70 76 80 75
Conjunctival suffusion 97 99 57 42 58 54 28.5
Vomiting 51 69 18 33 32 50 40
Myalgia 100 97 64 79 40 49 63 94
Arthralgia 51 36 31
Abdominal pain 31 26 28 40 43 41
Nausea 56 75 29 41 46 37
Dehydration 37
Cough 55 24 57 20 45 32 39
Hemoptysis 37 9 51 40 13 20
Hepatomegaly 83 69 28 15 17 27
Lymphadenopathy 19 24 49 21 21
Diarrhea 30 27 20 29 36 14 11
Rash 0 6 7 2
a
—, symptom not recorded.
Aseptic meningitis may be found in ≤25% of all leptospirosis cases and may account for a significant minority of all causes of aseptic meningitis (57, 236, 503). Patients with aseptic meningitis have tended to be younger than those with icteric leptospirosis (57, 328, 522). In their series of 616 cases, Alston and Broom (24) noted that 62% of children ≤14 years old presented with aseptic meningitis, whereas only 31% of patients aged 15 to 29 years did so and only 10% of those over 30 years of age. Mortality is almost nil in anicteric leptospirosis (180), but death resulting from massive pulmonary hemorrhage occurred in 2.4% of the anicteric patients in a Chinese outbreak (615).
The differential diagnosis must include common viral infections, such as influenza (18), human immunodeficiency virus seroconversion (290), and, in the tropics, dengue (332, 350, 501), in addition to the bacterial causes of fever of unknown origin, such as typhoid. Turner (585) provided a comprehensive list of other conditions that may be mimicked by leptospirosis, including encephalitis, poliomyelitis, rickettsiosis, glandular fever (infectious mononucleosis), brucellosis, malaria, viral hepatitis, and pneumonitis. Hantavirus infections must also be considered in the differential diagnosis for patients with pulmonary involvement (32). Petechial or purpuric lesions may occur (18, 115), and recently, cases of leptospirosis resembling viral hemorrhagic fevers have been reported in travelers returning from Africa (278, 402).

Icteric Leptospirosis

Icteric leptospirosis is a much more severe disease in which the clinical course is often very rapidly progressive. Severe cases often present late in the course of the disease, and this contributes to the high mortality rate, which ranges between 5 and 15%. Between 5 and 10% of all patients with leptospirosis have the icteric form of the disease (273). The jaundice occurring in leptospirosis is not associated with hepatocellular necrosis, and liver function returns to normal after recovery (476). Serum bilirubin levels may be high, and many weeks may be required for normalization (177). There are moderate rises in transaminase levels, and minor elevation of the alkaline phosphatase level usually occurs.
The complications of severe leptospirosis emphasize the multisystemic nature of the disease. Leptospirosis is a common cause of acute renal failure (ARF), which occurs in 16 to 40% of cases (2, 177, 473, 631). A distinction may be made between patients with prerenal azotemia (non-ARF) and those with ARF. Patients with prerenal azotaemia may respond to rehydration, and decisions regarding dialysis can be delayed for up to 72 h (417). In patients with ARF, oliguria (odds ratio [OR], 9.98) was a significant predictor of death (142).
Serum amylase levels are often raised significantly in association with ARF (18, 175, 422), but clinical symptoms of pancreatitis are not a common finding (174, 401, 439). Necrotizing pancreatitis has been detected at autopsy (175, 544). Thrombocytopenia (platelet count of <100 × 109/liter) occurs in ≥50% of cases and is a significant predictor for the development of ARF (176). However, thrombocytopenia in leptospirosis is transient and does not result from disseminated intravascular coagulation (179, 419).
The occurrence of pulmonary symptoms in cases of leptospirosis was first noted by Silverstein (525). Subsequent reports have shown that pulmonary involvement may be the major manifestation of leptospirosis in some clusters of cases (294, 510, 614, 664) and in some sporadic cases (63, 461). The severity of respiratory disease is unrelated to the presence of jaundice (283, 294). Patients may present with a spectrum of symptoms, ranging from cough, dyspnea, and hemoptysis (which may be mild or severe) to adult respiratory distress syndrome (15, 22, 59, 89, 110, 151, 165, 200, 399, 426, 472, 527, 664, 666). Intra-alveolar hemorrhage was detected in the majority of patients, even in the absence of overt pulmonary symptoms (171). Pulmonary hemorrhage may be severe enough to cause death (294, 581, 659, 664).
The incidence of respiratory involvement varies. In a Chinese series of anicteric cases, more than half had respiratory symptoms, while 67% had radiographic changes (614); in a similar Korean series, 67% of patients had respiratory symptoms and 64% had radiographic abnormalities (294), whereas in a series of jaundiced patients in Brazil, only 17% had clinical evidence of pulmonary involvement, but 33% had radiographic abnormalities (415). In a large Chinese series, moist rales were noted in 17% of cases (115). Rales are more common in icteric than in nonicteric leptospirosis (18). Concurrent hemoptysis and pulmonary infiltrates on chest radiographs were noted in 12% of 69 nonfatal cases in the Seychelles (659). Cigarette smoking was reported as a risk factor for the development of pulmonary symptoms (375).
Radiography generally reveals diffuse small opacities which may be widely disseminated or which may coalesce into larger areas of consolidation, with increasing severity of symptoms (342, 415, 525, 614, 659, 664). Pleural effusions may occur (342, 560). The patchy infiltrates which are commonly seen reflect areas of intra-alveolar and interstitial hemorrhage (294, 419, 472, 614, 664). Both alveolar infiltrates (OR 7.3) and dyspnea (OR 11.7) are poor prognostic indicators in severe leptospirosis (172). Similarly, in icteric leptospirosis in Brazil, respiratory insufficiency (OR 4.6) was associated with death (332).
Cardiac involvement in leptospirosis is common but may be underestimated. Fatal myocarditis was first described in 1935 (400). Clinical evidence of myocardial involvement, including abnormal T waves, was detected in 10% of 80 severe icteric cases in Louisiana (536), while similar electrocardiographic (ECG) abnormalities were detected in over 40% of patients in China, India, Sri Lanka, and the Philippines (353, 467, 471, 618), including both icteric and nonicteric cases. However, in a prospective study in Malaysia, identical ECG changes were found in patients with either leptospirosis or malaria (445), and it was concluded that such ECG changes were nonspecific. Other ECG abnormalities have been reported less frequently (470). The presence of myocarditis was strongly associated with the severity of pulmonary symptoms in anicteric Chinese patients (353). A mortality rate of 54% was reported in severe leptospirosis cases with myocarditis (341). Repolarization abnormalities on ECG were considered a poor prognostic indicator (OR 5.9) in severe leptospirosis cases (172), as were arrhythmias (OR 2.83) in a Brazilian series (332).

Ocular Involvement

Ocular manifestations of severe leptospirosis were noted in early reports (622, 624). Conjunctival suffusion is seen in the majority of patients in some series (377). Conjunctival suffusion in the presence of scleral icterus is said to be pathognomonic of Weil's disease (596). Anterior uveitis, either unilateral or bilateral, occurs after recovery from the acute illness in a minority of cases (53). Uveitis may present weeks, months, or occasionally years after the acute stage. Chronic visual disturbance, persisting 20 years or more after the acute illness, has been reported (521).
The incidence of ocular complications is variable, but this probably reflects the long time scale over which they may occur. In the United States the incidence was estimated at 3% (273), while in Romania an incidence of 2% was estimated between 1979 and 1985 (28). However, in abattoir workers with evidence of recent leptospirosis, the latter authors reported an incidence of 40% (28).
In most cases uveitis is presumed to be an immune phenomenon, but leptospires have been isolated from human and equine eyes (16, 209), and more recently, leptospiral DNA has been demonstrated in aqueous humor by PCR (114, 209, 389). Late-onset uveitis may result from an autoimmune reaction to subsequent exposure (211).
Recently, a large cluster of cases of uveitis was reported from Madurai in southern India following an outbreak of leptospirosis which occurred after heavy flooding (114, 477, 478). The majority of affected patients were males, with a mean age of 35 years (477). Eyes were involved bilaterally in 38 patients (52%), and panuveitis was present in 96% of eyes. Other significant ocular findings included anterior chamber cells, vitreous opacities, and vasculitis in the absence of visual deficit (114).

Other Complications

Acute infection in pregnancy has been reported to cause abortion (116) and fetal death (122, 214), but not invariably so. In one of the cases reported by Chung et al. (116), leptospires were isolated from amniotic fluid, placenta, and cord blood; the infant was mildly ill and was discharged at 2 weeks of age. In another case, a neonate developed jaundice and died 2 days after birth (356). Leptospires were demonstrated in the liver and kidneys by silver staining, but serological evidence of leptospiral infection in the mother was only obtained 2 weeks after delivery. Leptospires have been isolated from human breast milk (116), and in one case serovar hardjo was probably transmitted from an infected mother to her infant by breast-feeding (70).
Rare complications include cerebrovascular accidents (224, 346), rhabdomyolysis (133, 374, 537), thrombotic thrombocytopenic purpura (336), acute acalculous cholecystitis (44, 401, 600), erythema nodosum (157), aortic stenosis (91), Kawasaki syndrome (291, 636), reactive arthritis (633), epididymitis (285), nerve palsy (516, 578), male hypogonadism (437), and Guillain-Barré syndrome (403). Cerebral arteritis, resembling Moyamoya disease, has been reported in a series of patients from China (650).

Chronic or Latent Infection

Anecdotal reports suggest that leptospirosis may induce chronic symptoms analogous to those produced by other spirochetal infections, such as Lyme disease. However, there is very little objective evidence to support or disprove this hypothesis. The possibility of chronic human infection was suggested, without evidence of infection other than serology (420). A single case of late-onset meningitis following icteric leptospirosis has been described (406), in which leptospires were isolated from both cerebrospinal fluid (CSF) and urine. This patient exhibited a negligible antibody response to the infecting strain, suggesting the presence of an immune defect.
Of the sequelae of acute leptospirosis described above, uveitis is a potentially chronic condition and is a recognized chronic sequel of leptospirosis in humans and horses. Equine recurrent uveitis appears to be an autoimmune disease (358, 443), and Faine (211) suggested that late-onset uveitis in humans may result from an autoimmune reaction to subsequent exposure. Immune involvement in retinal pathology has been demonstrated in horses with spontaneous uveitis (318). Leptospires have been isolated from the human eye (16), and more recently, leptospiral DNA has been amplified from aqueous humor (114, 367, 389) of patients with uveitis. In these cases, uveitis has occurred relatively soon after the acute illness.
One follow-up study of 11 patients with a mean time of 22 years (range, 6 to 34 years) after recovery from acute leptospirosis has been reported (521). Four patients complained of persistent headaches since their acute illness. Two patients complained of visual disturbances; both had evidence of past bilateral anterior uveitis. No biochemical or hematologic abnormalities were detected to suggest continuing liver or renal impairment. No studies to date have attempted to confirm the persistence of leptospires in the tissues of patients who have subsequently died of other causes.

Pathology

Leptospirosis is characterized by the development of vasculitis, endothelial damage, and inflammatory infiltrates composed of moncytic cells, plasma cells, histiocytes, and neutrophils. On gross examination, petechial hemorrhages are common and may be extensive (35), and organs are often discolored due to the degree of icterus (459). The histopathology is most marked in the liver, kidneys, heart, and lungs (665), but other organs may also be affected according to the severity of the individual infection. The overall structure of the liver is not significantly disrupted, but there may be intrahepatic cholestasis (35, 169). Hypertrophy and hyperplasia of Kupffer cells is evident (148), and erythrophagocytosis has been reported (35, 169). In the kidneys, interstitial nephritis is the major finding, accompanied by an intense cellular infiltration composed of neutrophils and moncytes (447). Leptospires can be seen within the renal tubules (35, 447, 665). By electron microscopy, the tubular cell brush borders are denuded, the tubular basement membrane is thickened, and tubular cells exhibit mitochondrial depletion (147). In addition, minor changes are seen in the glomeruli, suggesting an anatomical basis for proteinuria in leptospirosis (147).
Pathological findings in the heart include interstitial myocarditis with infiltration of predominantly lymphocytes and plasma cells, petechial hemorrhages (particularly in the epicardium), mononuclear infiltration in the epicardium, pericardial effusions, and coronary arteritis (34, 146, 149, 202, 341, 472). In the lungs, pulmonary congestion and hemorrhage are common (35, 664), and infiltration of alveolar spaces by monocytes and neutrophils occurs (472). Hyaline membrane formation may occur (472, 666). Leptospires may be seen within endothelial cells in interalveolar septa, and attached to capillary endothelial cells (419).
In skeletal muscles, particularly of the leg, focal necrosis of isolated muscle fibers occurs, with infiltration of histiocytes, neutrophils, and plasma cells (169, 589). This evidence of myositis correlates with the intense myalgia reported by some patients (325). In brain, perivascular cuffing is observed (35, 665).

Treatment

Treatment of leptospirosis differs depending on the severity and duration of symptoms at the time of presentation. Patients with mild, flu-like symptoms require only symptomatic treatment but should cautioned to seek further medical help if they develop jaundice. Patients who present with more severe anicteric leptospirosis will require hospital admission and close observation. If the headache is particularly severe, a lumbar puncture usually produces a dramatic improvement.
The management of icteric leptospirosis requires admission of the patient to the intensive care unit initially. Patients with prerenal azotemia can be rehydrated initially while their renal function is observed, but patients in acute renal failure require dialysis as a matter of urgency. This is accomplished satisfactorily by peritoneal dialysis (250, 408, 556). Cardiac monitoring is also desirable during the first few days after admission (172).
Specific antibiotic treatment was reported soon after penicillin became available, with mixed results (42). Oxytetracycline was also used (497). Early experience was summarized by Alston and Broom in their monograph (24). Few well-designed and well-controlled studies of antibiotic treatment have been reported (252). A major difficulty in assessing the efficacy of antibiotic treatment results from the late presentation of many patients with severe disease, after the leptospires have localized in the tissues.
Doxycycline (100 mg twice a day for 7 days) was shown to reduce the duration and severity of illness in anicteric leptospirosis by an average of 2 days (382). Patients with severe disease were excluded from this study. Two randomized studies of penicillin produced conflicting results. One study included 42 patients with severe leptospirosis, of whom 19 were jaundiced (619); no patient required dialysis and there were no deaths. Intravenous penicillin was given at a dosage of 6 MU/day for 7 days and found to halve the duration of fever. A second study included 79 patients with icteric leptospirosis, of whom 4 died (178). Patients in the treatment group received intravenous penicillin at a dose of 8 MU/day for 5 days. No difference was observed between treatment and control groups in outcome or duration of the illness. There have been no controlled trials of penicillin versus doxycycline for treatment of leptospirosis.
A consistent finding of these studies has been the prevention of leptospiruria or a significant reduction in its duration (178, 382, 619). This finding alone is sufficient justification for antibiotic use, but any antibiotic treatment should be started as early as possible and should not replace other therapeutic measures. Jarisch-Herxheimer reactions have been reported after penicillin administration (200, 227, 598, 615). However, the apparently low risk should not preclude the use of penicillin (620).
Doxycycline (200 mg orally, once weekly) has been shown to be effective for short-term prophylaxis in high-risk environments (245, 511, 551). Similar findings have been reported in rhesus monkeys challenged experimentally (199). In a recent controlled trial, doxycycline significantly reduced the incidence of clinical disease but not serological evidence of infection (511). Anecdotal evidence suggests that doxycycline but not penicillin may be used successfully after exposure in laboratory accidents (239). An evidence-based review of antibiotic prophylaxis has been published (251).

Immunization

Immunity to leptospirosis is largely humoral (7) and is relatively serovar specific. Thus, immunization protects against disease caused by the homologous serovar or antigenically similar serovars only. Vaccines must therefore contain serovars representative of those present in the population to be immunized. Immunization has been widely used for many years as a means of inducing immunity in animals and humans, with limited success. Early vaccines were composed of suspensions of killed leptospires cultured in serum-containing medium, and side effects were common. Modern vaccines prepared using protein-free medium are generally without such adverse effects (64, 113). In developed countries, pigs and cattle are widely immunized, as are domestic dogs, but in most developing countries, vaccines which contain the locally relevant serovars are not available. Most vaccines require booster doses at yearly intervals.
Most bovine and porcine vaccines contain serovars hardjo and pomona; in North America, commercial vaccines also contain serovars canicola, grippotyphosa, and icterohaemorrhagiae. Protection against hardjo infection has been suboptimal, but one vaccine has recently been shown to offer good protection (C. A. Bolin, D. P. Alt, and R. L. Zuerner, Abstr. 2nd Int. Leptospirosis Soc. Meet., 1999. abstr. 18) and induces a cell-mediated immune response.
Canine vaccines generally contain serovars canicola and icterohaemorrhagiae. Vaccines protect against disease and renal shedding under experimental conditions (82), but transmission of serovar icterohaemorrhagiae from immunized dogs to humans has been reported (221). Moreover, immunized dogs may be infected with serovars other than those contained in commercial vaccines (83, 123, 206, 261, 464). A vaccine has been released recently which includes serovars grippotyphosa and pomona in addition to the traditional vaccine strains, in response to the increasing incidence of canine infection with these serovars.
Human vaccines have not been applied widely in Western countries. Immunization with polyvalent vaccines has been practiced in the Far East, where large numbers of cases occur in ricefield workers, such as in China (111) and Japan. In France, a monovalent vaccine containing only serovar icterohaemorrhagiae is licensed for human use. A vaccine containing serovars canicola, icterohaemorrhagiae, and pomona has been developed recently in Cuba (376).

PATHOGENESIS

The mechanisms by which leptospires cause disease are not well understood. A number of putative virulence factors have been suggested, but with few exceptions their role in pathogenesis remains unclear. These are reviewed briefly below, with an emphasis on recent developments.

Toxin Production

The production of toxins by pathogenic leptospires in vivo was inferred by Areán (35, 36). Endotoxic activity has been reported in several serovars (159, 300, 379, 421). Leptospiral LPS preparations exhibit activity in biological assays for endotoxin, but at much lower potencies (159, 300, 379).
Serovar pomona is notable for the production of hemolytic disease in cattle, while serovar ballum produces similar symptoms in hamsters. Hemolysins from several serovars have been characterized. The hemolysins of serovars ballum, hardjo, pomona, and tarassovi are sphingomyelinases (62, 154). Virulent strains exhibit chemotaxis towards hemoglobin (663). Plasma has been shown to prevent hemolysis (576). Phospholipase C activity has been reported in serovar canicola (655). A hemolysin from serovar lai is not associated with sphingomyelinase or phospholipase activity and is thought to be a pore-forming protein (343).
Strains of serovars pomona and copenhageni elaborate a protein cytotoxin (119, 394, 651), and cytotoxic activity has been detected in the plasma of infected animals (331). In vivo, this toxin elicited a typical histopathologic effect, with infiltration of macrophages and polymorphonuclear cells (651). A glycolipoprotein fraction with cytotoxic activity was recovered from serovar copenhageni (602). A similar fraction from serovar canicola inhibits Na+,K+ ATPase (662). Inhibitory activity was associated with unsaturated fatty acids, particularly palmitic and oleic acids (90). However, equal activity was demonstrated in L. biflexaserovar patoc (90), implying that other virulence factors might be of greater significance.

Attachment

Leptospires have been shown to attach to epithelial cells. Virulent leptospires adhere to renal epithelial cells in vitro, and adhesion is enhanced by subagglutinating concentrations of homologous antibody (48). Leptospires are phagocytosed by macrophages (118, 448) in the presence of specific antibody (49, 604). Inhibition of macrophage activity increased sensitivity to infection (301). Virulent leptospires become associated with neutrophils, but are not killed (117, 613). Phagocytosis occurs only in the presence of serum and complement (385), suggesting that the outer envelope of leptospires possesses an antiphagocytic component. Leptospiral LPS stimulated adherence of neutrophils to endothelial cells (166, 298) and platelets, causing aggregation and suggesting a role in the development of thrombocytopenia (298).

Immune Mechanisms

The second stage of acute leptospirosis is also referred to as the immune phase, in which the disappearance of the organism from the bloodstream coincides with the appearance of antibodies. The clinical severity of the disease often appears to be out of proportion to the histopathological findings. Immune-mediated disease has been proposed as one factor influencing the severity of the symptoms.
The production of immune complexes leading to inflammation in the central nervous system has been postulated (578). Levels of circulating immune complexes were correlated with severity of symptoms (233), and in patients who survived, circulating immune complex levels fell concurrently with clinical improvement. However, in experimental infections in guinea pigs, leptospiral antigen localized in the kidney interstitium, while immunoglobulin G (IgG) and C3 were deposited in the glomeruli and in the walls of small blood vessels (656).
The pathogenesis of equine recurrent uveitis appears to involve the production of antibodies against a leptospiral antigen which cross-react with ocular tissues (358, 443). Retinal damage in horses with uveitis is related to the presence of B lymphocytes in the retina (318). Antiplatelet antibodies have been demonstrated in human leptospirosis (144, 339). In leptospirosis and septicemia, such antibodies are directed against cryptantigens exposed on damaged platelets and do not play a causal role in the development of thrombocytopenia (592). Other autoantibodies have been detected in acute illness, including IgG anticardiolipin antibodies (495) and antineutrophil cytoplasmic antibodies (127). However, the significance of antineutrophil cytoplasmic antibodies in the pathogenesis of vascular injury in leptospirosis has been questioned (1).
Virulent leptospires induce apoptosis in vivo and in vitro (388, 391). In mice, apoptosis of lymphocytes is elicited by LPS via induction of tumor necrosis factor alpha (TNF-α) (299). Elevated levels of inflammatory cytokines such as TNF-α have been reported in patients with leptospirosis (203).

Surface Proteins

The outer membrane of leptospires contains LPS and several lipoproteins (outer membrane proteins [OMPs]) (254). The LPS is highly immunogenic and is responsible for serovar specificity (107, 152). An inverse relationship between expression of transmembrane OMPs and virulence was demonstrated in serovar grippotyphosa (259). Outer membrane lipoprotein LipL36 is downregulated in vivo (56) and is not recognized by the humoral immune response to host-adapted leptospirosis in hamsters (257). Other OMPs are also downregulated in vivo (418). Outer membrane components may be important in the pathogenesis of interstitial nephritis (56, 256). A fibronectin-binding protein produced only by virulent strains was described recently (390).

Immunity

Immunity to leptospirosis is largely humoral in nature (7). Passive immunity can be conferred by antibodies alone (6, 316, 505). A serovar-specific antigen (F4) extracted from LPS (215) lacked endotoxic activity and induced protective immunity in rabbits, guinea pigs, and mice (216). A similar antigen (TM), which inhibited agglutination by homologous antisera (3), was shown to be distinct from F4 (10) but had a common epitope (12). Sodium dodecyl sulfate extracts of whole cells induced production of protective antibody, which was also agglutinating and complement fixing (326). Immunity is strongly restricted to the homologous serovar or closely related serovars. Serovar specificity is conferred by the LPS antigens (317, 392, 605). Broadly reactive genus-specific antigens have also been described (13, 411, 431, 538).
Several of the leptospiral OMPs are highly conserved (256, 515), and the potential for subunit vaccines which can generate broadly cross-protective immunity has been suggested by recent studies using OmpL1 and LipL41 (258), which induced synergistic protection.
Cell-mediated immune responses to leptospirosis have been reported (480). However, suppression of the cell-mediated immune response has been reported (652), with reduction in the number of CD4+ lymphocytes and in their responsiveness to some mitogens. Anecdotal evidence for lack of a significant cell-mediated component in the immune response to leptospirosis was provided by the clinical course of cases occurring in patients with AIDS (143, 416).

LABORATORY DIAGNOSIS

General Clinical Laboratory Findings

In anicteric disease, the erythrocyte sedimentation rate is elevated, and white cell counts range from below normal to moderately elevated (180). Liver function tests show a slight elevation in aminotransferases, bilirubin, and alkaline phosphatase in the absence of jaundice. Urinalysis shows proteinuria, pyuria, and often microscopic hematuria. Hyaline and granular casts may also be present during the first week of illness (180).
Lumbar puncture will usually reveal a normal or slightly elevated CSF pressure (57) and may serve to reduce the intensity of headache. CSF examination may initially show a predominance of polymorphs or lymphocytes, but later examination almost invariably shows that lymphocytes predominate (57, 96). CSF protein may be normal or elevated, while CSF glucose is usually normal. In patients with severe jaundice, xanthochromia may occur (96, 180, 634). CSF abnormalities are common in the second week of illness, and CSF pleocytosis can persist for weeks (180).
In severe leptospirosis, a peripheral leukocytosis occurs with a shift to the left, whereas in dengue, atypical lymphocytes are commonly observed. Thrombocytopenia is common and may be marked (176). Renal function impairment is indicated by raised plasma creatinine levels. The degree of azotemia varies with severity of illness (24). In icteric leptospirosis, liver function tests generally show a significant rise in bilirubin, with lesser increases in transaminases and marginal increases in alkaline phosphatase levels (177). The increase in bilirubin is generally out of proportion to the other liver function test values (179). Similar findings were reported for serum creatinine phophokinase levels (313). Serum amylase may also be elevated, particularly in patients with ARF.
The nonspecific nature of these changes can only suggest a diagnosis of leptospirosis. For confirmation of the diagnosis, specific microbiological tests are necessary.

Microscopic Demonstration

Leptospires may be visualized in clinical material by dark-field microscopy or by immunofluorescence or light microscopy after appropriate staining. Dark-field microscopic examination of body fluids such as blood, urine, CSF, and dialysate fluid has been used but is both insensitive and lacking specificity. Approximately 104leptospires/ml are necessary for one cell per field to be visible by dark-field microscopy (587). A quantitative buffy coat method was recently shown to have a sensitivity of approximately 103 leptospires/ml (335). A method which involved repeated microscopic examination of double-centrifuged anticoagulated blood demonstrated leptospires in 32% of patients whose leptospirosis was confirmed by animal inoculation (634). Microscopy of blood is of value only during the first few days of the acute illness, while leptospiremia occurs. In volunteers infected with serovar grippotyphosa, leptospires were detected as early as 4 days prior to the development of symptoms (24). None of the positive samples reported by Wolff (634) were taken more than 6 days after onset of symptoms. Most authorities agree that there are too few leptospires in CSF for detection by dark-field microscopy (24, 634). Direct dark-field microscopy of blood is also subject to misinterpretation of fibrin or protein threads, which may show Brownian motion (213, 587, 634).
Staining methods have been applied to increase the sensitivity of direct microscopic examination. These have included immunofluorescence staining of bovine urine (72, 284), water, and soil (275) and immunoperoxidase staining of blood and urine (562). A variety of histopathological stains have been applied to the detection of leptospires in tissues. Leptospires were first visualized by silver staining (542), and the Warthin-Starry stain is widely used for histologic examination. Immunofluorescence microscopy is used extensively to demonstrate leptospires in veterinary specimens (195). More recently, immunohistochemical methods have been applied (256, 589, 664, 665).

Antigen Detection

Detection of leptospiral antigens in clinical material would offer greater specificity than dark-field microscopy while having the potential for greater sensitivity. An evaluation of several methods concluded that radioimmunoassay (RIA) could detect 104 to 105 leptospires/ml and an enzyme-linked immunosorbent assay (ELISA) method could detect 105 leptospires/ml, but countercurrent immunoelectrophoresis and staphylococcal coagglutination were much less sensitive (4). RIA was more sensitive than dark-field microscopy but less sensitive than culture when applied to porcine urine (109). A double-sandwich ELISA could detect 104 leptospires of serovar hardjo but was less sensitive for other serovars (103). A chemiluminescent immunoassay (612) was applied to human blood and urine (433) but was no more sensitive than earlier ELISA. More recently, immunomagnetic antigen capture was combined with fluoroimmunoassay to detect as few as 102 leptospires/ml in urine of cattle infected with serovar hardjo (654). Inhibitory substances have been reported in urine (4, 109, 654), indicating the need for treatment of urine prior to testing.

Isolation of Leptospires

Leptospiremia occurs during the first stage of the disease, beginning before the onset of symptoms, and has usually finished by the end of the first week of the acute illness (384). Therefore, blood cultures should be taken as soon as possible after the patient's presentation. One or two drops of blood are inoculated into 10 ml of semisolid medium containing 5-fluorouracil at the patient's bedside. For the greatest recovery rate, multiple cultures should be performed, but this is rarely possible. Inoculation of media with dilutions of blood samples may increase recovery (548). Rapid detection of leptospires by radiometric methods has been described (366). Leptospires survive in conventional blood culture media for a number of days (434). Rarely, leptospires have been isolated from blood weeks after the onset of symptoms (303).
Other samples that may be cultured during the first week of illness include CSF and dialysate. Urine can be cultured from the beginning of the second week of symptomatic illness. The duration of urinary excretion varies but may last for several weeks (46). Survival of leptospires in voided human urine is limited, so urine should be processed immediately (587) by centrifugation, followed by resuspending the sediment in phosphate-buffered saline (to neutralize the pH) and inoculating into semisolid medium containing 5-fluorouracil.
Cultures are incubated at 28 to 30°C and examined weekly by dark-field microscopy for up to 13 weeks before being discarded. Contaminated cultures may be passed through a 0.2-μm or 0.45-μm filter before subculture into fresh medium (487).

Identification of leptospiral isolates.

Isolated leptospires are identified either by serological methods or, more recently, by molecular techniques. Traditional methods relied on cross-agglutinin absorption (162). The number of laboratories which can perform these identification methods is very small. The use of panels of monoclonal antibodies (327, 333, 334, 520, 563, 564) allows laboratories which can perform the microscopic agglutination test to identify isolates with relative rapidity. Molecular methods have become more widely used (279, 451) and are discussed below.

Susceptibility testing.

Leptospires are susceptible to β-lactams, macrolides, tetracyclines, fluoroquinolones, and streptomycin (21, 213). MBCs are several orders of magnitude higher than MICs (423, 554). Problems in the determination of susceptibility include the long incubation time required (183), the use of media containing serum (423, 648), and the difficulty in quantifying growth accurately. These constraints have limited the development of rapid, standardized methods for susceptibility testing.

Serological Diagnosis

Most cases of leptospirosis are diagnosed by serology. Antibodies are detectable in the blood approximately 5 to 7 days after the onset of symptoms. Serological methods can be divided into two groups: those which are genus specific (Table 8) and those which are serogroup specific. The use of agglutination tests was described soon after the first isolation of the organism (373, 506). At that time few serovars were recognized, and there was little attempt to standardize the methodology between laboratories. Many other methodologies have since been applied to serological diagnosis, but the definitive serological investigation in leptospirosis remains the microscopic agglutination test (MAT).
Table 8.
Table 8. Genus-specific serological tests for diagnosis of leptospirosis
Method Reference(s)
Complement fixation test 463
Sensitized erythrocyte lysis 105
Macroscopic slide agglutination 234
Immunfluorescence 33, 580
Patoc slide agglutination test 76, 362, 381, 557
Indirect hemagglutination 295, 431, 499, 546, 547
Counterimmunoelectrophoresis 410, 567
ELISA 11, 363, 565, 566
Microcapsule agglutination 38, 39, 514
Dot-ELISA 438, 617, 350a
IgM dipstick 253, 533, 350a
Latex agglutination 534

Microscopic agglutination test.

The reference method for serological diagnosis of leptospirosis is the MAT, in which patient sera are reacted with live antigen suspensions of leptospiral serovars. After incubation, the serum-antigen mixtures are examined microscopically for agglutination, and the titers are determined. Formerly, the method was known as the agglutination-lysis test because of the formation of lysis balls (506) or lysis globules (596) of cellular debris in the presence of high-titered antiserum. However, these are tightly agglutinated clumps of leptospires containing live cells and not debris (586).
Several modifications of earlier methods (124, 235, 549, 634) led to an MAT method which can be performed and read in microtiter trays. Protocols for performing the MAT have been described in detail (17, 210, 322, 548). The MAT is a complex test to control, perform, and interpret (586). Live cultures of all serovars required for use as antigens must be maintained. This applies equally whether the test is performed with live or formalin-killed antigens. The repeated weekly subculture of large numbers of strains presents hazards for laboratory workers, and laboratory-acquired infections have been reported (16, 460). Other drawbacks include the continuous risk of cross-contamination of the antigen cultures, necessitating periodic verification of each serovar. MAT titers are affected by the culture medium in which the antigens are grown (409).
The range of antigens used should include serovars representative of all serogroups (210, 586) and all locally common serovars (579). Antibody titers to local isolates are often higher than titers to laboratory stock strains of serovars within the same serogroup. It is usual to include one of the serovars of the nonpathogenic species L. biflexa (276, 557). Such a wide range of antigens is used in order to detect infections with uncommon or previously undetected serovars (320). Contrary to a widely held belief, the MAT is a serogroup-specific assay. In many reports which purport to show serovar specificity, a limited range of serogroups were tested, each represented by only a single serovar. Moreover, few studies have attempted to correlate the presumptive serogroup determined by MAT with the results of culture. However, the ability of convalescent-phase MAT titers to predict even the infecting serogroup may be as low as 40% (P. N. Levett, Abstr. 2nd Int. Leptospirosis Soc. Meet. 1999, abstr. 29).
The MAT is read by dark-field microscopy. The end point is the highest dilution of serum at which 50% agglutination occurs. Because of the difficulty in detecting when 50% of the leptospires are agglutinated, the end point is determined by the presence of approximately 50% free, unagglutinated leptospires compared to the control suspension (210). Considerable effort is required to reduce the subjective effect of observer variation, even within laboratories.
Interpretation of the MAT is complicated by the high degree of cross-reaction that occurs between different serogroups, especially in acute-phase samples. This is to some extent predictable, and patients often have similar titers to all serovars of an individual serogroup. Of note, “paradoxical” reactions (Fig.3), in which the highest titers are detected to a serogroup unrelated to the infecting one, are also common (24, 577). The broad cross-reactivity in the acute phase, followed by relative serogroup specificity in convalescent-phase samples, results from the detection in the MAT of both IgM and IgG antibodies (6, 41, 112, 404, 431, 491, 578) and the presence of several common antigens among leptospires (6, 108, 355).
Fig. 3.
Fig. 3. Paradoxical immune response to acute infection with serovar bim, in which the presumptive serogroup (Autumnalis) was identified during follow-up (a), and copenhageni, in which serogroup Icterohaemorrhagiae was never identified as the predominant serogroup (b).
Paired sera are required to confirm a diagnosis with certainty. A fourfold or greater rise in titer between paired sera confirms the diagnosis regardless of the interval between samples. The interval between the first and second samples greatly depends on the delay between onset of symptoms and presentation of the patient. If symptoms of overt leptospirosis are present, an interval of 3 to 5 days may be adequate to detect rising titers. However, if the patient presents earlier in the course of the disease or if the date of onset is not known precisely, then an interval of 10 to 14 days between samples is more appropriate. Less often, seroconversion does not occur with such rapidity, and a longer interval between samples (or repeated sampling) is necessary. MAT serology is insensitive, particularly in early acute-phase specimens (33, 77, 140). Moreover, patients with fulminant leptospirosis may die before seroconversion occurs (84, 140, 484).
Acute infection is suggested by a single elevated titer detected in association with an acute febrile illness. The magnitude of such a titer is dependent on the background level of exposure in the population and hence the seroprevalence. Thus, in the current CDC case definition, a titer of ≥200 is used to define a probable case with a clinically compatible illness (97). Although this may be appropriate for use in a population in which exposure to leptospirosis is uncommon, a higher cut-off titer is necessary for defining probable cases of leptospirosis in most tropical countries. In areas where leptospirosis is endemic, a single titer of ≥800 in symptomatic patients is generally indicative of leptospirosis (212), but titers as high as ≥1,600 have been recommended (17).
Titers following acute infection may be extremely high (≥25,600) and may take months or even years to fall to low levels (24, 67, 359, 493). Often, it is not possible to distinguish a predominant serogroup until months after infection, as cross-reacting titers decline at different rates (359). If possible, it is important to examine several sera taken at intervals after the acute disease in order to determine the presumptive infecting serogroup. Rarely, seroconversion may be delayed for many weeks after recovery, and longer serological follow-up will be necessary to confirm the diagnosis.
Some patients have serological evidence of previous infection with a different leptospiral serogroup. In these cases, serological diagnosis is complicated further by the “anamnestic response,” in which the first rise in antibody titer is usually directed against the infecting serovar from the previous exposure. Only later does it become possible to identify the serovar or serogroup responsible for the current infection, as the titer of specific antibody rises. Paradoxical reactions also occur in patients who have such infections, and interpretation of serology is further complicated.
Formalized antigens have been used in the MAT to overcome some of the difficulties associated with the use of live antigens. Titers obtained with these antigens are somewhat lower, and more cross-reactions are detected (210, 243, 368, 435, 548, 634). Agglutination of formalin-treated antigens is qualitatively different from that seen with live antigens (17); however, for laboratories without the staff or expertise to maintain live antigens, formalin-treated and lyophilized antigens may represent a good alternative.
The MAT is also the most appropriate test to employ in epidemiological serosurveys, since it can be applied to sera from any animal species and the range of antigens used can be expanded or decreased as required. It is usual to use a titer of ≥100 as evidence of past exposure (210). However, conclusions about infecting serovars cannot be drawn without isolates; at best, the MAT data can give a general impression about which serogroups are present within a population.

Other serological tests.

Because of the complexity of the MAT, rapid screening tests for leptospiral antibodies in acute infection have been developed (Table 8). Complement fixation (CF) was widely used (24, 586, 595, 634), but methods were not standardized. CF was applied to veterinary diagnosis, but species-specific differences were noted (488). CF tests have generally been replaced by ELISA methods (11, 365, 440, 565, 566). IgM antibodies become detectable during the first week of illness (11, 112, 173, 351, 617), allowing the diagnosis to be confirmed and treatment initiated while it is likely to be most effective. IgM detection has repeatedly been shown to be more sensitive than MAT when the first specimen is taken early in the acute phase of the illness (140, 484, 632).
IgM antibodies have been detected by ELISA in CSF from patients with icteric leptospirosis (94). In patients with meningitis without a proven etiology, IgM was detected in the CSF in 15% (522). IgM has been detected in saliva (524), and a dot-ELISA using polyester fiber was developed to facilitate collection of saliva directly onto the support material (523).
ELISA methods have been applied in a number of modifications. An IgM-specific dot-ELISA was developed in which polyvalent leptospiral antigen was dotted onto nitrocellulose filter disks in microtiter tray wells, allowing the use of smaller volumes of reagents. Further modifications of this approach have been used to detect IgG and IgA in addition to IgM (524) and have employed an immunodominant antigen (485) and a polyester fabric-resin support in place of nitrocellulose (523). A commercial IgM dot-ELISA dipstick has been shown to be as sensitive as a microtiter plate IgM-ELISA (350a). Another dipstick assay (253) has been extensively evaluated in several populations (512, 533, 661). A dot immunoblot assay using colloidal gold conjugate allowed completion of the assay within 30 min (455).
In contrast to the applications of ELISA for diagnosis of human infection, in which broadly reactive assays are generally desirable and few serovar-specific assays have been developed (395), veterinary applications have been directed towards detection of serovar-specific antibodies, particularly for detection of infection in food animals. ELISA methods have described for detection of serovar pomona (134, 573) and hardjo (5, 58, 573, 653) infection in cattle and hardjo in sheep (9). Several assays are available commercially for serodiagnosis of bovine hardjo infection and have been evaluated (642). IgM detection by ELISA has also been applied to canine diagnosis (264, 265, 623).
A macroscopic slide agglutination test was described in which 12 serovars were combined into four pools for the rapid screening of sera from humans and animals (234). Despite the use of an expanded antigen range, false-negative results were reported for sera from populations in areas of endemic leptospirosis (635). Several modifications of this test have used a single serovar antigen, usually serovar patoc (76, 364, 369, 621). Some studies have reported that the patoc slide test is insensitive (369, 546, 616), but a commercial slide agglutination assay was recently found to be as sensitive and specific as an IgM-ELISA while remaining reactive for a shorter time after recovery than either the IgM-ELISA or the MAT (77).
A number of methods using sensitized red blood cells have been described. The extraction of an erythrocyte-sensitizing substance led to the development of both a hemolytic assay requiring complement (135, 136) and a hemagglutination assay (383, 547), and a number of modifications of the latter have been described (295, 499). These assays detect both IgM and IgG antibodies (351, 431). The indirect hemagglutination assay (IHA) developed at CDC (547) was shown to have a sensitivity of 92% and specificity of 95% compared with the MAT (546). This assay is available commercially and for many years as the only U.S. Food and Drug Administration-approved product for serological diagnosis of leptospirosis. Recent estimates of the sensitivity of the IHA in populations in which leptospirosis is endemic have varied. In one study, IHA detected all patients with leptospirosis but was positive in only 44% of first acute-phase samples taken a mean of 5 days after onset of symptoms (351). Other studies have reported lower overall sensitivities, partly due to differences in case ascertainment and study design (181, 661).
A microcapsule agglutination test using a synthetic polymer in place of red blood cells (39, 514) has been evaluated extensively in Japan and China (40, 139). In an international multicenter evaluation, the microcapsule agglutination test was more sensitive than either the MAT or an IgM-ELISA in early-acute-phase samples (38), but failed to detect infections caused by some serovars (38, 513). An advantage of this direct agglutination method is that it can be applied without modification to sera from other animal species (37).
Other techniques applied to the detection of leptospiral antibodies include immunofluorescence (33, 580), RIA (323), counterimmunoelectrophoresis (410, 567, 657), and thin-layer immunoassay (50). These methods have not been widely used.

Molecular Diagnosis

Leptospiral DNA has been detected in clinical material by dot-blotting (393, 569) and in situ hybridization (568). A recombinant probe specific for pathogenic serovars was prepared from serovar lai (143). Probes specific for serovar hardjobovis were developed (344, 594, 673) and applied to the detection of leptospires in bovine urine (72). However, the sensitivity of 32P-labeled probes was approximately 103 leptospires (393, 569, 673), much lower than the sensitivity of PCR, and probes have not been used extensively for diagnosis since PCR became available.
Several primer pairs for PCR detection of leptospires have been described, some based on specific gene targets (483), most frequently 16S or 23S rRNA genes (287, 386, 407, 607, 637, 639, 667) and repetitive elements (428, 502, 643, 670, 671), while others have been constructed from genomic libraries (247, 248, 324, 594). However, few have been shown to amplify leptospiral DNA from either human (247, 386) or veterinary (378, 559, 594, 606, 643, 670) clinical material, and of these, only two methods have been subject to extensive clinical evaluation (84, 387). Both methods were found to be more sensitive than culture, but differences in analysis of the data render direct comparisons between the two approaches impossible.
In one analysis, culture and PCR were positive in 48 and 62% of confirmed cases of leptospirosis, respectively, but serology was positive in 97% (84). However, PCR was positive for two patients who died before seroconversion and was also positive for 18% of seronegative first acute-phase samples.
Both these approaches have limitations. The primers described by Merien et al. (386) amplify a 331-bp fragment of therrs (16S rRNA) gene of both pathogenic and nonpathogenic leptospires, which in the unlikely event of contamination of specimens with nonpathogenic leptospires might produce a false-positive result, whereas the G1 and G2 primers described by Gravekamp et al. (247) do not amplify L. kirschneri serovars, necessitating the use of two primer pairs for detection of all pathogenic serovars (248).
Despite these potential shortcomings, these two primer pairs have been the most widely used for clinical studies. Leptospiral DNA has been amplified from serum (84, 247, 387), urine (46, 84, 387), aqueous humor (389), CSF (387, 492, 601), and a number of tissues obtained at autopsy (unpublished data).
The detection of leptospiral DNA in bovine urine has also been investigated. Primers which amplified several serovars of serogroup Sejroe were described (593), and a method specific for serovar hardjo genotype hardjobovis was developed (643). An assay based on the IS1533 insertion sequence (670) facilitated both detection and identification of serovars directly from urine. Another assay was developed and applied to both bovine and porcine urine samples (607). To overcome the problem of inhibitors present in bovine urine, a magnetic immunocapature PCR assay for serovar hardjo was developed (559).
A recent study evaluated five PCR methods, culture, and immunofluorescence for detection of serovar hardjo in bovine urine samples (606). Primers derived from rRNA gene sequences were the least specific, and none of the methods was 100% sensitive. A combination of two detection methods chosen from PCR, immunofluorescence, and culture was the most sensitive.
A limitation of PCR-based diagnosis of leptospirosis is the inability of most PCR assays to identify the infecting serovar. While this is not significant for individual patient management, the identity of the serovar has significant epidemiological and public health value. Strategies designed to overcome this obstacle have included restriction endonuclease digestion of PCR products (85, 502), direct sequencing of amplicons (424), and single-strand conformation analysis (SSCP) (380, 647). Leptospiral genomospecies but not individual serovars can be differentiated following PCR by electrophoresis in nondenaturing polyacrylamide gels, followed by silver staining (424), without the additional step of purification and denaturing.
PCR has been used to distinguish pathogenic from nonpathogenic serovars (407, 444, 639). Recently, a fluorescent-probe 5′ exonuclease PCR assay was described for the rapid detection of pathogenic leptospires (637).

Molecular Typing

Because of the difficulties associated with serological identification of leptospiral isolates, there has been great interest in molecular methods for identification and subtyping (279, 561). Methods employed have included digestion of chromosomal DNA by restriction endonucleases (REA), restriction fragment length polymorphism (RFLP), ribotyping, PFGE, and a number of PCR-based approaches.
REA has been studied extensively (270, 288, 370, 372, 490, 555, 563, 575). Distinct genotypes within serovar hardjo were demonstrated (490). Bovine isolates from North America have all been found to be of genotype hardjobovis, of which subtypes A, B, and C could be recognized (574). In Northern Ireland, both genotypes hardjobovis and hardjoprajitno were found among bovine isolates (371). Antigenic differences were also reported among hardjobovis isolates (345). Moreover, serovar balcanica isolates in North America were indistinguishable from genotype hardjobovis isolates by REA (574). Further analysis of RFLP in genotype hardjobovis isolates by REA, Southern blotting, and PFGE has shown the existence of multiple genetic clones resulting from genomic rearrangement (675). These clones were usually localized within geographical locations and thus are of epidemiological significance (675).
Similar subserovar differences were detected within serovar pomona, isolates from North America being identified as subtype kennewicki (563, 575), while European isolates were of serovar pomona (270, 563) or mozdok (269, 270). More recently, differences between subtype kennewicki isolates were correlated with host animal source (71). Differences between serovars copenhageni and icterohaemorrhagiae were demonstrated by some workers (372), but not all (288, 555). However, all isolates of these two serovars are indistinguishable by PFGE (281).
Ribotyping has demonstrated reasonably good correlation with the phylogenetic classification of leptospira into 11 genomospecies. UsingEcoRI for digestion and 16S and 23S rRNA fromEscherichia coli as the probe, a large database was constructed (451, 452). Many serovars gave unique profiles, while other serovars could not be distinguished from each other by ribotyping, particularly those that were known previously to be closely related, such as icterohaemorrhagiae and copenhageni (288, 555). Ribotypes of serovars within genomospecies could be grouped together by the possession of common fragments. This database is available at the Institut Pasteur website (http://www.pasteur.fr/recherche/Leptospira/Ribotyping.html ). Ribotyping has been shown to discriminate accurately between the serovar hardjo genotypes hardjobovis and hardoprajitno (453).
An alternative approach to ribotyping used three restriction enzymes and a PCR-derived 16S rDNA probe. Use of only 16S rDNA gave fewer bands, but this was counterbalanced to some extent by the use of multiple restriction enzymes, giving three different patterns for each serovar (286). Relatively few serovars were examined but all gave distinct ribotypes with the exception of serovars icterohaemorrhagiae and copenhageni. A range of other probes have been used to generate RFLPs (429, 593, 672, 673). A probe based on the repetitive sequence element from serovar hardjo genotype hardjobovis was also used to detect leptospires in bovine urine (673).
PFGE has proven useful to characterize leptospiral serovars (279). In contrast to its application in strain typing of other organisms, PFGE has shown that the genomes of leptospiral serovars are remarkably conserved, both over time and across wide geographical distributions (279, 281). Importantly, recent clinical isolates gave the same banding patterns as reference strains of the same serovar which have been maintained for many years by repeated subculture (279). Using the enzymeNotI, most but not all serovars gave unique PFGE patterns.L. interrogans serovars bratislava, lora, jalna, and muenchen gave identical patterns when digested with NotI but were differentiated when digested with SgrAI (282). Other serovars which were difficult to differentiate included L. borgpetersenii serovars arborea and castellonis. The L. interrogans serovars copenhageni and icterohaemorrhagiae were indistinguishable by PFGE, confirming their close relationship. PFGE analysis has become the de facto standard for molecular characterization of leptospiral isolates, and other molecular typing methods will in future have to be validated against this method.
A limiting factor in all methods which analyze chromosomal DNA is the requirement for large quantities of purified DNA. As a result, several methods based on the analysis of PCR-amplified sections of leptospiral DNA have been employed. Sequence variation within the 285-bp fragment amplified by the G1 and G2 primers (248) led to different electrophoretic mobilities which were detected by polyacrylamide gel electrophoresis and silver staining (424). This approach allowed serovars of L. interrogans sensu stricto to be differentiated from L. noguchii serovars.
Sequence variation is also exploited in SSCP. Using this method, serovars prevalent in China were shown to have different mobilities corresponding to L. interrogans and L. borgpetersenii (647). The Chinese isolates were studied using a sequence amplified from the 16S rRNA gene, the highly conserved nature of which may account for the inability to distinguish serovars from one another. In contrast, SSCP analysis of the G1-G2 amplicon allows serovar identification within each genomospecies studied (380). A restriction on the use of the latter sequence is the inability of the G1 and G2 primers to amplify L. kirschneri (248). An alternative application of these primers is their use under low-stringency conditions, generating a mixture of specific and nonspecific products (150). Under these conditions, the G1 and G2 primers amplify all species, includingL. biflexa. Polymorphisms were detected which allowed discrimination of serovars with the exception of closely related serovars, including copenhageni and icterohaemorrhagiae (85, 150).
The presence of multiple copy insertion sequences has been exploited for serovar identification (481, 502, 670, 671). Methods based on IS1533 have limited application because of the absence of this insertion sequence in L. interrogans (sensu stricto) and L. noguchii (481, 670). By amplifying the sequences between adjacent copies of IS1500, numerous genetic subgroups within serovar pomona type kennewickii were distinguished (671).
RFLP analysis of PCR-amplified 16S and 23S rRNA genes allowed the grouping of 48 serovars into 16 mapped restriction site polymorphism profiles (469). Using this approach, the genomospecies ofLeptospira could be identified, and the genotypes hardjobovis and hardjoprajitno of serovar hardjo were clearly distinguished (453). The method was simplified to yield only five profiles by using a single restriction enzyme (638). One of the potential advantages of this RFLP approach is the ability to amplify leptospiral DNA from clinical material and to identify the infecting serovar or genomospecies rapidly in the absence of an isolate. Other workers have used primers that amplify only a restricted range of serovars (85, 502), limiting the utility of the approach unless several primer sets are used (85).
DNA fingerprinting using arbitrary primers (625, 629) has been studied extensively (85, 128, 129, 237, 453, 469), using different primers and conditions. Direct comparison between the results of these studies is therefore impossible, but it is clear that reproducibility is difficult to achieve without absolute standardization of experimental procedure. Profiles are affected markedly by the primer used, the quantity and quality of the DNA template (128, 380, 599), and the electrophoresis conditions (129). The greatest value of arbitrary primer techniques lies in their ability to differentiate between isolates when the range of potential serovars is limited, allowing rapid identification of freshly isolated strains (85, 128, 237). Arbitrary-primed PCR was used to derive species-specific probes for identification of L. interrogans (sensu stricto), L. borgpetersenii, and L. kirschneri by dot blotting (347). A cluster of 43 L. interrogans sensu strico isolates from a number of Brazilian outbreaks were shown to have identical arbitrary-primed PCR fingerprints (449) despite the inclusion of isolates of serovars copenhageni and canicola.

CONCLUSION

The etiology and epidemiology of leptospirosis have been understood for many years, and this knowledge has led to the development of effective preventive strategies. In developed countries, leptospirosis continues to be a disease of considerable economic significance in animal husbandry, but the major burden of human disease remains in tropical and subtropical developing countries. Several recent outbreaks of leptospirosis have drawn attention to the potential effects of climate change and human activity on the incidence of the disease and the broad spectrum of clinical manifestations. The development of several promising approaches to rapid diagnosis has been based largely on the recognition that early initiation of antibiotic therapy is important in acute disease, but also on the need for simpler assays which can be used more widely. However, many of these diagnostic advances will be unavailable to those populations for which they would be most useful. At a more fundamental level, understanding of the mechanisms of pathogenesis remains incomplete, but recent advances in the molecular biology of leptospires offer the prospect of more rapid progress in the future.

ACKNOWLEDGMENTS

I thank the many colleagues who have assisted me with access to the literature, particularly Esther Maria Fajardo, Peter Gaskin, Albert Ko, Diane Van Alstyne, and Rob Weyant and the staff of the Information Center, CDC, Atlanta, Ga.

REFERENCES

1.
Abdulkader R., Sabbaga E., Meireles L., and Radu A. Vascular injury in acute renal failure due to leptospirosis is not associated with antineutrophil cytoplasmic antibody Nephron 65 1993 156
2.
Abdulkader R. C. R. M. Acute renal failure in leptospirosis Renal Fail. 19 1997 191 -198
3.
Adachi Y. and Yanagawa R. Inhibition of leptospiral agglutination by the type-specific main antigens of leptospiras Infect. Immun. 17 1977 466 -467
4.
Adler B., Chappel R. J., and Faine S. The sensitivities of different immunoassays for detecting leptospiral antigen Zentbl. Bakteriol. 252 1982 405 -413
5.
Adler B., Cousins D. V., Faine S., and Robertson G. M. Bovine IgM and IgG response to Leptospira interrogans serovar hardjo as measured by enzyme immunoassay Vet. Microbiol. 7 1982 577 -585
6.
Adler B. and Faine S. The antibodies involved in the human immune response to leptospiral infection J. Med. Microbiol. 11 1978 387 -400
7.
Adler B. and Faine S. Host immunological mechanisms in the resistance of mice to leptospiral infections Infect. Immun. 17 1977 67 -72
8.
Adler B., Faine S., Christopher W. L., and Chappel R. J. Development of an improved selective medium for isolation of leptospires from clinical material Vet. Microbiol. 12 1986 377 -381
9.
Adler B., Faine S., and Gordon L. M. The enzyme-linked immunosorbent assay (ELISA) as a serological test for detecting antibodies against Leptospira interrogans serovar hardjo in sheep Aust. Vet. J. 57 1981 414 -417
10.
Adler B., Faine S., and Yanagawa R. Comparative studies on two antigens (F4 and TM) extracted from leptospires J. Clin. Microbiol. 12 1980 7 -9
11.
Adler B., Murphy A. M., Locarnini S. A., and Faine S. Detection of specific anti-leptospiral immunoglobulins M and G in human serum by solid-phase enzyme-linked immunosorbent assay J. Clin. Microbiol. 11 1980 452 -457
12.
Adler B. A. and Faine S. A Pomona serogroup-specific, agglutinating antigen in Leptospira, identified by monoclonal antibodies Pathology 15 1983 247 -250
13.
Adler B. A. and Faine S. Species- and genus-specific antigens in Leptospira, revealed by monoclonal antibodies and enzyme immunoassay Zentbl. Bakteriol. 255 1983 317 -322
14.
Agrawal P. K. and Srivastava D. K. Outbreak of Weil's disease in a food fad commune in India BMJ 293 1986 1646 -1647
15.
Alani F. S. S., Mahoney M. P., Ormerod L. P., Wright P. A., and Garrues M. Leptospirosis presenting as atypical pneumonia, respiratory failure and pyogenic meningitis J. Infect. 27 1993 281 -283
16.
Alexander A., Baer A., Fair J. R., Gochenour W. S., King J. H., and Yager R. N. Leptospiral uveitis: report of a bacteriologically confirmed case Arch. Ophthalmol. 48 1952 292 -297
17.
Alexander A. D. Serological diagnosis of leptospirosis Manual of clinical laboratory immunology 3rd ed. Rose N. R., Friedman H., and Fahey J. L. 1986 435 -439 American Society for Microbiology Washington, D.C.
18.
Alexander A. D., Benenson A. S., Byrne R. J., Dı́az-Rivera R. S., Evans L. B., Gochenour W. S., Hall H. E., Hightower J. A., Jeffries H., de Jesús J., Martı́nez E., Paniagua M., Pons J. A., Ramos-Morales F., Rodrı́guez-Molina R., Swisher K. Y., Woodward T. E., and Yager R. H. Leptospirosis in Puerto Rico Zoonoses Res. 2 1963 152 -227
19.
Alexander A. D., Evans L. B., Baker M. F., Baker H. J., Ellison D., and Marriapan M. Pathogenic leptospiras isolated from Malaysian surface waters Appl. Microbiol. 29 1975 30 -33
20.
Alexander A. D., Lessel E. F., Evans L. B., Franck E., and Green S. S. Preservation of leptospiras by liquid-nitrogen refrigeration Int. J. Syst. Bacteriol. 22 1972 165 -169
21.
Alexander A. D. and Rule P. L. Penicillins, cephalosporins, and tetracyclines in treatment of hamsters with fatal leptospirosis Antimicrob. Agents Chemother. 30 1986 835 -839
22.
Allen P., Raftery S., and Phelan D. Massive pulmonary haemorrhage due to leptospirosis Intensive Care Med. 15 1989 322 -324
23.
Alston J. M. Leptospiral jaundice among sewer-workers Lancet i 1935 806 -809
24.
Alston J. M. and Broom J. C. Leptospirosis in man and animals. E. & S. 1958 Livingstone Edinburgh, U.K
25.
Anderson B. S. and Minette H. P. Leptospirosis in Hawaii: shifting trends in exposure, 1907–1984 Int. J. Zoonoses 13 1986 76 -88
26.
Anderson D. C., Folland D. S., Fox M. D., Patton C. M., and Kaufmann A. F. Leptospirosis: a common-source outbreak due to leptospires of the grippotyphosa serogroup Am. J. Epidemiol. 107 1978 538 -544
27.
Anderson D. C., Geistfeld J. G., Maetz H. M., Patton C. M., and Kaufmann A. F. Leptospirosis in zoo workers associated with bears Am. J. Trop. Med. Hyg. 27 1978 210 -211
28.
Andreescu N., Tacorian D., Duminica E., Filip M., and Sosin A. Investigarea serologica in complicatiile oculare ale leptospirozelor la om Bacteriol. Virusol. Parazitol. Epidemiol. 33 1988 41 -46
29.
André-Fontaine G., Peslerbe X., and Ganiere J. P. Occupational hazard of unnoticed leptospirosis in water ways maintenance staff Eur. J. Epidemiol. 8 1992 228 -232
30.
Andrew D. E. and Marrocco G. R. Leptospirosis in New England JAMA 238 1977 2027 -2028
31.
Annear D. I. Recovery of leptospires after dry storage for ten years Int. J. Syst. Bacteriol. 24 1974 399 -401
32.
Antoniadis A., Alexiou-Daniel S., Fidani L., and Bautz E. F. K. Comparison of the clinical and serologic diagnosis of haemorrhagic fever with renal syndrome (HFRS) and leptospirosis Eur. J. Epidemiol. 11 1995 91 -92
33.
Appassakij H., Silpapojakul K., Wansit R., and Woodtayakorn J. Evaluation of the immunofluorescent antibody test for the diagnosis of human leptospirosis Am. J. Trop. Med. Hyg. 52 1995 340 -343
34.
Areán V. M. Leptospiral myocarditis Lab. Investig. 6 1957 462 -471
35.
Areán V. M. The pathologic anatomy and pathogenesis of fatal human leptospirosis (Weil's disease) Am. J. Pathol. 40 1962 393 -423
36.
Areán V. M., Sarasin G., and Green J. H. The pathogenesis of leptospirosis: toxin production by Leptospira icterohaemorrhagiae Am. J. Vet. Res. 25 1964 836 -843
37.
Arimitsu Y., Fukumura K., and Shintaki Y. Distribution of leptospirosis among stray dogs in the Okinawa Islands, Japan: comparison of the microcapsule and microscopic agglutination tests Br. Vet. J. 145 1989 473 -477
38.
Arimitsu Y., Kmety E., Ananyina Y., Baranton G., Ferguson I. R., Smythe L., and Terpstra W. J. Evaluation of the one-point microcapsule agglutination test for diagnosis of leptospirosis Bull. WHO 72 1994 395 -399
39.
Arimitsu Y., Kobayashi S., Akama K., and Matuhasi T. Development of a simple serological method for diagnosing leptospirosis: a microcapsule agglutination test J. Clin. Microbiol. 15 1982 835 -841
40.
Arimitsu Y., Matuhasi T., Kobayashi S., Sato T., and Cui J. J. Serodiagnosis of leptospirosis in China by the one-point MCA method Epidemiol. Infect. 99 1987 393 -398
41.
Awad-Masalmeh A. and Willinger H. Evaluation of 2-mercapto-ethanol treatment in serodiagnosis of swine leptoispirosis Microbiologica 6 1983 133 -143
42.
Baber M. D. and Stuart R. D. Leptospirosis canicola: a case treated with penicillin Lancet ii 1946 594 -596
43.
Babudieri B. Animal reservoirs of leptospirosis Ann. N.Y. Acad. Sci. 70 1958 393 -413
44.
Baelen E. and Roustan J. Leptospirosis associated with acute acalculous cholecystitis J. Clin. Gastroenterol. 25 1997 704 -706
45.
Bahaman A. R., Ibrahim A. L., Stallman N. D., and Tinniswood R. D. The bacteriological prevalence of leptospiral infection in cattle and buffaloes in West Malaysia Epidemiol. Infect. 100 1988 239 -246
46.
Bal A. E., Gravekamp C., Hartskeerl R. A., de Meza-Brewster J., Korver H., and Terpstra W. J. Detection of leptospires in urine by PCR for early diagnosis of leptospirosis J. Clin. Microbiol. 32 1994 1894 -1898
47.
Ballard S. A., Segers R. P. A. M., Bleumink-Pluym N., Fyfe J., Faine S., and Adler B. Molecular analysis of the hsp (groE) operon of Leptospira interrogans serovar copenhageni Mol. Microbiol. 8 1993 739 -751
48.
Ballard S. A., Williamson M., Adler B., Vinh T., and Faine S. Interactions of virulent and avirulent leptospires with primary cultures of renal epithelial cells J. Med. Microbiol. 21 1986 59 -67
49.
Banfi E., Cinco M., Bellini M., and Soranzo M. R. The role of antibodies and serum complement in the interaction between macrophages and leptospires J. Gen. Microbiol. 128 1982 813 -816
50.
Banfi E., Cinco M., Delia S., Castagnari L., Vullo V., Mastroianni C. M., and Contini C. New trends in the rapid serodiagnosis of leptospirosis Zentbl. Bakteriol. 257 1984 503 -507
51.
Baril C., Herrmann J. L., Richaud C., Margarita D., and Girons I. S. Scattering of the rRNA genes on the physical map of the circular chromosome of Leptospira interrogans serovar icterohaemorrhagiae J. Bacteriol. 174 1992 7566 -7571
52.
Baril C. and Saint Girons I. Sizing of the Leptospira genome by pulsed-field agarose gel electrophoresis FEMS Microbiol. Lett. 71 1990 95 -100
53.
Barkay S. and Garzozi H. Leptospirosis and uveitis Ann. Ophthalmol. 16 1984 164 -168
54.
Barkin R. M. and Glosser J. W. Leptospirosis—an epidemic in children Am. J. Epidemiol. 98 1973 184 -191
55.
Barkin R. M., Guckian J. C., and Glosser J. W. Infection by Leptospira ballum: a laboratory-associated case South. Med. J. 67 1974 155 -156
56.
Barnett J. K., Barnett D., Bolin C. A., Summers T. A., Wagar E. A., Cheville N. F., Hartskeerl R. A., and Haake D. A. Expression and distribution of leptospiral outer membrane components during renal infection of hamsters Infect. Immun. 67 1999 853 -861
57.
Beeson P. B. and Hankey D. D. Leptospiral meningitis Arch. Intern. Med. 89 1952 575 -583
58.
Bercovich Z., Taaijke R., and Bokhout B. A. Evaluation of an ELISA for the diagnosis of experimentally induced and naturally occurring Leptospira hardjo infections in cattle Vet. Microbiol. 21 1990 255 -262
59.
Berendsen H. H., Rommes J. H., Hylkema B. S., Meinesz A. F., and Sluiter H. J. Adult respiratory failure with leptospirosis Ann. Intern. Med. 101 1984 402
60.
Berg H. C., Bromley D. B., and Charon N. W. Leptospiral motility Relations between structure and function in the prokaryotic cell. 28th Symposium of the Society for General Microbiology. Stanier R. Y., Rogers H. J., and Ward J. B. 1978 285 -294 Cambridge University Press Cambridge, U.K
61.
Berman S. J., Tsai C. C., Holmes K. K., Fresh J. W., and Watten R. H. Sporadic anicteric leptospirosis in South Vietnam Ann. Intern. Med. 79 1973 167 -173
62.
Bernheimer A. W. and Bey R. F. Copurification of Leptospira interrogans serovar pomona hemolysin and sphingomyelinase C Infect. Immun. 54 1986 262 -264
63.
Bethlem N., Lemle A., and Pereira N. G. Leptospirosis Semin. Respir. Med. 12 1991 58 -67
64.
Bey R. F. and Johnson R. C. Protein-free and low-protein media for the cultivation of Leptospira Infect. Immun. 19 1978 562 -569
65.
Blackmore D. K., Bell L., and Schollum L. Leptospirosis in meat inspectors: preliminary results of a serological survey N. Z. Med. J. 90 1979 415 -418
66.
Blackmore D. K. and Schollum L. M. Risks of contracting leptospirosis on the dairy farm N. Z. Med. J. 95 1982 649 -652
67.
Blackmore D. K., Schollum L. M., and Moriarty K. M. The magnitude and duration of titres of leptospiral agglutinins in human sera N. Z. Med. J. 97 1984 83 -86
68.
Blagoveshchenskaia N. M. On the epidemiology of anicteric leptospirosis J. Microbiol. Epidemiol. Immunobiol. 28 1957 240 -244
69.
Bolin C. Leptospirosis Emerging diseases of animals. Brown C. and Bolin C. 2000 185 -200 ASM Press Washington, D.C.
70.
Bolin C. A. and Koellner P. Human-to-human transmission of Leptospira interrogans by milk J. Infect. Dis. 158 1988 246 -247
71.
Bolin C. A. and Zuerner R. L. Correlation between DNA restriction fragment length polymorphisms in Leptospira interrogans serovar pomona type kennewicki and host animal source J. Clin. Microbiol. 34 1996 424 -425
72.
Bolin C. A., Zuerner R. L., and Trueba G. Comparison of three techniques to detect Leptospira interrogans serovar hardjo type hardjo-bovis in bovine urine Am. J. Vet. Res. 50 1989 1001 -1003
73.
Boursaux-Eude C., Saint Girons I., and Zuerner R. L. IS1500, an IS3-like element from Leptospira interrogans Microbiology 141 1995 2165 -2173
74.
Boursaux-Eude C., Saint Girons I., and Zuerner R. L. Leptospira genomics Electrophoresis 19 1998 589 -592
75.
Bowdoin C. D. A new disease identity (?) J. Med. Assoc. Ga. 31 1942 437 -442
76.
Bragger J. M. and Adler B. A card test for the serodiagnosis of human leptospirosis J. Clin. Pathol. 29 1976 198 -202
77.
Brandão A. P., Camargo E. D., da Silva E. D., Silva M. V., and Abrão R. V. Macroscopic agglutination test for rapid diagnosis of human leptospirosis J. Clin. Microbiol. 36 1998 3138 -3142
78.
Brandling-Bennett A. D. and Pinheiro F. Infectious diseases in Latin America and the Caribbean: are they really emerging and increasing? Emerg. Infect. Dis. 2 1996 59 -61
79.
Braun J. L. Epidemiology of leptospirosis in Iowa-a study of sporadic and epidemic cases J. Am. Vet. Med. Assoc. 138 1961 532 -536
80.
Brendle J. J., Rogul M., and Alexander A. D. Deoxyribonucleic acid hybridization among selected leptospiral serotypes Int. J. Syst. Bacteriol. 24 1974 205 -214
81.
Brenner D. J., Kaufmann A. F., Sulzer K. R., Steigerwalt A. G., Rogers F. C., and Weyant R. S. Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp. nov. and four new Leptospira genomospecies Int. J. Syst. Bacteriol. 49 1999 839 -858
82.
Broughton E. S. and Scarnell J. Prevention of renal carriage of leptospirosis in dogs by vaccination Vet. Rec. 117 1985 307 -311
83.
Brown C. A., Roberts A. W., Miller M. A., David D. A., Brown S. A., Bolin C. A., Jarecki-Black J., Greene C. E., and Miller-Liebl D. Leptospira interrogans serovar grippotyphosa infection in dogs J. Am. Vet. Med. Assoc. 209 1996 1265 -1267
84.
Brown P. D., Gravekamp C., Carrington D. G., Van de Kemp H., Hartskeerl R. A., Edwards C. N., Everard C. O. R., Terpstra W. J., and Levett P. N. Evaluation of the polymerase chain reaction for early diagnosis of leptospirosis J. Med. Microbiol. 43 1995 110 -114
85.
Brown P. D. and Levett P. N. Differentiation of Leptospira species and serovars by PCR-restriction endonuclease analysis, arbitrarily primed PCR and low-stringency PCR J. Med. Microbiol. 46 1997 173 -181
86.
Buchanan G. Spirochaetal jaundice. Special Report Series, no. 113. 1927Medical Research Council, London, U.K.
87.
Buckland F. E. and Stuart R. D. Mud fever (leptospirosis) in the British army in France Lancet ii 1945 331 -333
88.
Bulach D. M., Kalambaheti T., de La Peña-Moctezuma A., and Adler B. Functional analysis of genes in the rfb locus of Leptospira borgpetersenii serovar hardjo subtype hardjobovis Infect. Immun. 68 2000 3793 -3798
89.
Burke B. J., Searle J. F., and Mattingly D. Leptospirosis presenting with profuse haemoptysis BMJ 2 1976 982
90.
Burth P., Younes-Ibrahim M., Gonçalez F. H. F. S., Costa E. R., and Castro Faria M. V. Purification and characterization of a Na+, K+ ATPase inhibitor found in an endotoxin of Leptospira interrogans Infect. Immun. 65 1997 157 -1560
91.
Butler C. S. and Endara S. A. Leptospirosis complicated by severe aortic stenosis Anaesth. Intensive Care 28 2000 434 -437
92.
Cacciapuoti B., Ciceroni L., Maffei C., Di Stanislao F., Strusi P., Calegari L., Lupido R., Scalise G., Cagnoni G., and Renga G. A waterborne outbreak of leptospirosis Am. J. Epidemiol. 126 1987 535 -545
93.
Caccione R. A., Cascelli E. S., Saravı́ M. A., and Martı́nez E. S. Brote de leptospirosis en niños de Longhamps, Pcia de Buenos Aires, Argentina: daignostico de laboratorio Rev. Argent. Microbiol. 9 1977 126 -128
94.
Camargo E. D., Silva M. V., Vaz A. J., Batista L., Brandão A. P., Ferreira A. W., Romero E. C., and Barbosa P. R. S. ELISA-IgM applied to cerebrospinal fluid in human leptospirosis Serodiagn. Immunother. Infect. Dis. 7 1995 19 -22
95.
Campagnolo E. R., Warwick M. C., Marx H. L., Cowart R. P., Donnell H. D., Bajani M. D., Bragg S. L., Esteban J. E., Alt D. P., Tappero J. W., Bolin C. A., and Ashford D. A. Analysis of the 1998 outbreak of leptospirosis in Missouri in humans exposed to infected swine J. Am. Vet. Med. Assoc. 216 2000 676 -682
96.
Cargill W. H. and Beeson P. B. The value of spinal fluid examination as a diagnostic procedure in Weil's disease Ann. Intern. Med. 27 1947 396 -400
97.
Centers for Disease Control and Prevention Case definitions for infectious conditions under public health surveillance Morb. Mortal. Wkly. Rep. 46 RR-10 1997 49
98.
Centers for Disease Control and Prevention Outbreak of acute febrile illness among athletes participating in triathlons—Wisconsin and Illinois, 1998 Morb. Mortal. Wkly. Rep. 47 1998 585 -588
99.
Centers for Disease Control and Prevention Outbreak of acute febrile illness among participants in EcoChallenge Sabah 2000—Malaysia, 2000 Morb. Mortal. Wkly. Rep. 49 2000 816 -817
100.
Centers for Disease Control and Prevention Outbreak of acute febrile illness and pulmonary hemorrhage—Nicaragua, 1995 Morb. Mortal. Wkly. Rep. 44 1995 841 -843
101.
Centers for Disease Control and Prevention Summary of notifiable diseases, United States 1994 Morb. Mortal. Wkly. Rep. 43 53 1994 1 -80
102.
Centers for Disease Control and Prevention Update: leptospirosis and unexplained acute febrile illness among athletes participating in triathlons—Illinois and Wisconsin, 1998 Morb. Mortal. Wkly. Rep. 47 1998 673 -676
103.
Champagne M. J., Higgins R., Fairbrother J. M., and Dubreuil D. Detection and characterization of leptospiral antigens using a biotin/avidin double-antibody sandwich enzyme-linked immunosorbent assay and immunoblot Can. J. Vet. Res. 55 1991 239 -245
104.
Chan O. Y., Paul D. R., and Sng E. H. Leptospirosis among abattoir workers—a serological study Singapore Med. J. 28 1987 293 -296
105.
Chang R. S., Smith D. J. W., McComb D. E., Sharp C. F., and Tonge J. I. The use of erythrocyte sensitizing substance in the diagnosis of leptospiroses. II. The sensitized erythrocyte lysis test Am. J. Trop. Med. Hyg. 6 1957 101 -107
106.
Chang S. L., Buckingham M., and Taylor M. P. Studies on Leptospira icterohaemorrhagiae. IV. Survival in water and sewage: destruction in water by halogen compounds, synthetic detergents, and heat J. Infect. Dis. 82 1948 256 -266
107.
Chapman A. J., Adler B., and Faine S. Antigens recognised by the human immune repsonse to infection with Leptospira interrogans serovar hardjo J. Med. Microbiol. 25 1988 269 -278
108.
Chapman A. J., Adler B., and Faine S. Genus-specific antigens in Leptospira revealed by immunoblotting Zentbl. Bakteriol. 264 1987 279 -283
109.
Chappel R. J., Adler B., Ballard S. A., Faine S., Jones R. T., Millar B. D., and Swainger J. A. /85. Enzymatic radioimmunoassay for detecting Leptospira interrogans serovar pomona in the urine of experimentally-infected pigs Vet. Microbiol. 10 1984 279 -286
110.
Chee H. D., Ossenkoppele G. J., Bronsveld W., and Thijs L. G. Adult respiratory distress syndrome in Leptospira icterohaemorragiae infection Intensive Care Med. 11 1985 254 -256
111.
Chen T. Development and present status of leptospiral vaccine and technology of vaccine production in China Jpn. J. Bacteriol. 40 1985 755 -762
112.
Chernukha Y. G., Shishkina Z. S., Baryshev P. M., and Kokovin I. L. The dynamics of IgM- and IgG-antibodies in leptospiral infection in man Zentbl. Bakteriol. 236 1976 336 -343
113.
Christopher W. L., Adler B., and Faine S. Immunogenicity of leptospiral vaccines grown in protein-free medium J. Med. Microbiol. 15 1982 493 -501
114.
Chu K. M., Rathinam R., Namperumalsamy P., and Dean D. Identification of Leptospira species in the pathogenesis of uveitis and determination of clinical ocular characteristics in South India J. Infect. Dis. 177 1998 1314 -1321
115.
Chung H.-L., Ch'iu F.-H., Wu H.-T., Hou T.-C., and K'uang C.-H. Leptospirosis. A clinical and statistical study of 182 cases Chin. Med. J. 77 1958 207 -235
116.
Chung H.-L., Ts'ao W.-C., Mo P.-S., and Yen C. Transplacental or congenital infection of leptospirosis Chin. Med. J. 82 1963 777 -782
117.
Cinco M. and Banfi E. Interactions between human polymorphonuclear leukocytes and one strain of pathogenic Leptospira (L. interrogans sp.) and one of saprophytic Leptospira (L. biflexa sp.) FEMS Microbiol. Lett. 19 1983 51 -54
118.
Cinco M., Banfi E., and Soranzo M. R. Studies on the interaction between macrophages and leptospires J. Gen. Microbiol. 124 1981 409 -413
119.
Cinco M., Banfi M., Furlani A., and Scarcia V. Cytotoxic activity of supernatant extracts of virulent and saprophytic leptospires Zentbl. Bakteriol. 248 1980 260 -267
120.
Cockburn T. A., Vavra J. D., Spencer S. S., Dann J. R., Peterson L. J., and Reinhard K. R. Human leptospirosis associated with a swimming pool, diagnosed after eleven years Am. J. Hyg. 60 1954 1 -7
121.
Coggins W. J. Leptospirosis due to Leptospira pomona. An outbreak of nine cases JAMA 181 1962 1077 -1078
122.
Coghlan J. D. and Bain A. D. Leptospirosis in human pregnancy followed by death of the foetus BMJ 1 1969 228 -230
123.
Cole J. R., Sangster L. T., Sulzer C. R., Pursell A. R., and Ellinghausen H. C. Infections with Encephalitozoon cuniculi and Leptospira interrogans, serovars grippotyphosa and ballum, in a kennel of foxhounds J. Am. Vet. Med. Assoc. 180 1982 435 -437
124.
Cole J. R., Sulzer C. R., and Pursell A. R. Improved microtechnique for the leptospiral microscopic agglutination test Appl. Microbiol. 25 1973 976 -980
125.
Collares-Pereira M., Cristino J. A. G. M., and Pereira A. T. Plasmid analysis of Leptospira Leptospirosis. Proceedings of the Leptospirosis Research Conference 1990. Kobayashi Y. 1991 462 -473 University of Tokyo Press Tokyo, Japan
126.
Communicable Disease Surveillance Centre Leptospirosis outbreak in Eco Challenge 2000 participants Commun. Dis. Rep. 10 2000 341
127.
Constantin A., Marin F., Oksman F., and Bouteiller G. Antineutrophil cytoplasmic antibodies in leptospirosis J. Rheumatol. 23 1996 411
128.
Corney B. G., Colley J., Djordjevic S. P., Whittington R., and Graham G. C. Rapid identification of some Leptospira isolates from cattle by random amplified polymorphic DNA fingerprinting J. Clin. Microbiol. 31 1993 2927 -2932
129.
Corney B. G., Colley J., and Graham G. C. Simplified analysis of pathogenic leptospiral serovars by random amplified polymorphic DNA fingerprinting J. Med. Microbiol. 46 1997 927 -932
130.
Corwin A., Ryan A., Bloys W., Thomas R., Deniega B., and Watts D. A waterborne outbreak of leptospirosis among United States military personnel in Okinawa, Japan Int. J. Epidemiol. 19 1990 743 -748
131.
Costa S. and Troisier J. Un cas de spirochétose ictéro-hémorragique Bull. Mém. Soc. Méd. Hôpitaux de Paris 40 1916 1635 -1639
132.
Cotter T. J. Weil's disease in North Queensland BMJ 1 1936 51 -56
133.
Coursin D. B., Updike S. J., and Maki D. G. Massive rhabdomyolysis and multiple organ dysfunction syndrome caused by leptospirosis Intensive Care Med. 26 2000 808 -812
134.
Cousins D. V., Robertson G. M., and Hustas L. The use of the enzyme-linked immunosorbent assay (ELISA) to detect the IgM and IgG antibody response to Leptospira interrogans serovars hardjo, pomona and tarassovi in cattle Vet. Microbiol. 10 1985 439 -450
135.
Cox C. D. Hemolysis of sheep erythrocytes sensitized with leptospiral extracts Proc. Soc. Exp. Biol. Med. 90 1955 610 -615
136.
Cox C. D., Alexander A. D., and Murphy L. C. Evaluation of the hemolytic test in the serodiagnosis of human leptospirosis J. Infect. Dis. 101 1957 210 -218
137.
Crawford R. P., Heinemann J. M., McCulloch W. F., and Diesch S. L. Human infections associated with waterborne leptospires, and survival studies on serotype pomona J. Am. Vet. Med. Assoc. 159 1971 1477 -1484
138.
Crawford S. M. and Miles D. W. Leptospira hebdomadis associated with an outbreak of illness in workers on a farm in North Yorkshire Br. J. Ind. Med. 37 1980 397 -398
139.
Cui J. J., Xiao G. X., Chen T. Z., Zhu G. F., Sato T., Seki M., Kobayahsi S., and Arimitsu Y. Further evaluation of one-point microcapsule agglutination test for diagnosis of leptospirosis Epidemiol. Infect. 106 1991 561 -565
140.
Cumberland P. C., Everard C. O. R., and Levett P. N. Assessment of the efficacy of the IgM enzyme-linked immunosorbent assay (ELISA) and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis Am. J. Trop. Med. Hyg. 61 1999 731 -734
141.
Daher E., Zanetta D. M., Cavalcante M. B., and Abdulkader R. C. Risk factors for death and changing patterns in leptospirosis acute renal failure Am. J. Trop. Med. Hyg. 61 1999 630 -634
142.
Dai B., Xiao J., and Shen C. Identification of pathogenic leptospires by recombinant DNA probes Chin. Med. Sci. J. 9 1994 209 -214
143.
da Silva M. V., Batista L., Camargo E. D., Leitao P. A., Szalkay V. G., Rosenthal C., Vaz A. J., and de Souza A. M. Leptospirosis in patients with anti-HIV antibodies: report of 2 cases Rev. Soc. Bras. Med. Trop. 23 1990 229 -231
144.
Davenport A., Rugman F. P., Desmond M. J., and Ganta R. Is thrombocytopenia seen in patients with leptospirosis immunologically mediated? J. Clin. Pathol. 42 1989 439 -440
145.
Dawson B. and Hume W. E. Jaundice of infective origin Q. J. Med. 10 1916 90 -131
146.
De Biase L., De Curtis G., Paparoni S., Sciarra D., and Campa P. P. Fatal leptospiral myocarditis G. Ital. Cardiol. 17 1987 992 -994
147.
de Brito T., Freymüller E., Penna D. O., Santos H. S., Soares de Almeida S., Galvão P. A. A., and Pereira V. G. Electron microscopy of the biopsied kidney in human leptospirosis Am. J. Trop. Med. Hyg. 14 1965 397 -403
148.
de Brito T., Machado M. M., Montans S. D., Hosino S., and Freymüller E. Liver biopsy in human leptospirosis: a light and electron microscopy study Virchows Arch. Pathol. Anat. 342 1967 61 -69
149.
de Brito T., Morais C. F., Yasuda P. H., Lancellotti C. P., Hoshino-Shimizu S., Yamashiro E., and Alves V. A. F. Cardiovascular involvement in human and experimental leptospirosis: pathologic findings and immunohistochemical detection of leptospiral antigen Ann. Trop. Med. Parasitol. 81 1987 207 -214
150.
de Caballero O. L. S. D., Dias Neto E., Koury M. C., Romanha A. J., and Simpson A. J. G. Low-stringency PCR with diagnostically useful primers for identification of Leptospira serovars J. Clin. Microbiol. 32 1994 1369 -1372
151.
de Koning J., van der Hoeven J. G., and Meinders A. E. Respiratory failure in leptospirosis (Weil's disease) Neth. J. Med. 47 1995 224 -229
152.
de la Peña-Moctezuma A., Bulach D. M., Kalambaheti T., and Adler B. Comparative analysis of the LPS biosynthetic loci of the genetic subtypes of serovar Hardjo: Leptospira interrogans subtype Hardjoprajitno and Leptospira borgpetersenii subtype Hardjobovis FEMS Microbiol. Lett. 177 1999 319 -326
153.
de Lima S. C., Sakata E. E., Santo C. E., Yasuda P. H., Stiliano S. V., and Ribeiro F. A. Outbreak of human leptospirosis by recreational activity in the municipality of Sao Jose dos Campos, Sao Paulo: seroepidemiological study Rev. Inst. Med. Trop. Sao Paulo 32 1990 474 -479
154.
del Real G., Segers R. P., van der Zeijst B. A., and Gaastra W. Cloning of a hemolysin gene from Leptospira interrogans serovar hardjo Infect. Immun. 57 1989 2588 -2590
155.
Demers R. Y., Frank R., Demers P., and Clay M. Leptospiral exposure in Detroit rodent control workers Am. J. Public Health 75 1985 1090 -1091
156.
Demers R. Y., Thiermann A., Demers P., and Frank R. Exposure to Leptospira icterohaemorrhagiae in inner-city and suburban children: a serologic comparison J. Fam. Pract. 17 1983 1007 -1011
157.
Derham R. L. J. Leptospirosis as a cause of erythema nodosum BMJ 2 1976 403 -404
158.
de Souza D. Considerações sobre enchentes e leptospirose humana no municipio de São Paulo Rev. Esc. Enferm. USP 20 1986 243 -250
159.
de Souza L. and Koury M. C. Chemical and biological properties of endotoxin from Leptospira interrogans serovars canicola and icterohaemorrhagiae Braz. J. Med. Biol. Res. 25 1992 467 -475
160.
Diesch S. L. Survival of leptospires in cattle manure J. Am. Vet. Med. Assoc. 159 1971 1513 -1517
161.
Diesch S. L. and McCulloch W. F. Isolation of pathogenic leptospires from waters used for recreation Public Health Rep. 81 1966 299 -304
162.
Dikken H. and Kmety E. Serological typing methods of leptospires Methods in Microbiology Bergan T. and Norris J. R. 11 1978 259 -307 Academic Press London, U.K
163.
Ding M. and Yelton D. B. Cloning and analysis of the leuB gene of Leptospira interrogans serovar pomona J. Gen. Microbiol. 139 1993 1093 -1103
164.
Dinger J. E. Duurzaamheid der smetkracht van leptospirenkweeken Ned. Tijdschr. Geneeskd. 72 1932 1511 -1519
165.
Dive A. M., Bigaignon G., and Reynaert M. Adult respiratory distress syndrome in Leptospira icterohaemorrhagiae infection Intensive Care Med. 13 1987 214
166.
Dobrina A., Nardon E., Vecile E., Cinco M., and Patriarca P. Leptospira icterohemorrhagiae and leptospire peptidoglycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes Infect. Immun. 63 1995 2995 -2999
167.
Doeleman F. P. J. Ziekte van Weil, rechstreeks overgebracht van mensch op mensch Ned. Tijdschr. Geneeskd. 76 1932 5057
168.
Doherty J. P., Adler B., Rood J. I., Billington S. J., and Faine S. Expression of two conserved leptospiral antigens in Escherichia coli J. Med. Microbiol. 28 1989 143 -149
169.
Dooley J. R. and Ishak K. G. Leptospirosis Pathology of tropical and extraordinary diseases Binford C. H. and Connor D. H. 1 1976 101 -106 Armed Forces Institute of Pathology Washington, D.C.
170.
Douglin C. P., Jordan C., Rock R., Hurley A., and Levett P. N. Risk factors for severe leptospirosis in the parish of St. Andrew, Barbados Emerg. Infect. Dis. 3 1997 78 -80
171.
du Couëdic L., Courtin J. P., Poubeau P., Tanguy B., di Francia M., and Arvin-Berod C. Hémorragies intra-alvéolaires patentes et occultes au cours des leptospiroses Rev. Mal. Respir. 15 1998 61 -67
172.
Dupont H., Dupont-Perdrizet D., Perie J. L., Zehner-Hansen S., Jarrige B., and Daijardin J. B. Leptospirosis: prognostic factors associated with mortality Clin. Infect. Dis. 25 1997 720 -724
173.
Edelweiss E. L. and Mailloux M. The curve of immunoglobulins in human leptospirosis Int. J. Zoonoses 9 1982 51 -55
174.
Edwards C. N. Leptospirosis and pancreatitis Pediatr. Infect. Dis. J. 18 1999 399 -400
175.
Edwards C. N. and Everard C. O. R. Hyperamylasemia and pancreatitis in leptospirosis Am. J. Gastroenterol. 86 1991 1665 -1668
176.
Edwards C. N., Nicholson G. D., and Everard C. O. R. Thrombocytopenia in leptospirosis Am. J. Trop. Med. Hyg. 31 1982 827 -829
177.
Edwards C. N., Nicholson G. D., Hassell T. A., Everard C. O. R., and Callender J. Leptospirosis in Barbados: a clinical study West Indian Med. J. 39 1990 27 -34
178.
Edwards C. N., Nicholson G. D., Hassell T. A., Everard C. O. R., and Callender J. Penicillin therapy in icteric leptospirosis Am. J. Trop. Med. Hyg. 39 1988 388 -390
179.
Edwards C. N., Nicholson G. D., Hassell T. A., Everard C. O. R., and Callender J. Thrombocytopenia in leptospirosis: the absence of evidence for disseminated intravascular coagulation Am. J. Trop. Med. Hyg. 35 1986 352 -354
180.
Edwards G. A. and Domm B. M. Human leptospirosis Medicine 39 1960 117 -156
181.
Effler P. V., Domen H. Y., Bragg S. L., Aye T., and Sasaki D. M. Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis in Hawaii J. Clin. Microbiol. 38 2000 1081 -1084
182.
Elder J. K., Pepper P. M., Hill M. W. M., and Ward W. H. The significance of leptospiral titres associated with bovine abortion Aust. Vet. J. 62 1985 258 -262
183.
Ellinghausen H. C. Growth, cultural characteristics, and antibacterial sensitivity of Leptospira interrogans serovar hardjo Cornell Vet. 73 1983 225 -239
184.
Ellinghausen H. C. and McCullough W. G. Nutrition of Leptospira pomona and growth of 13 other serotypes: fractionation of oleic albumin complex and a medium of bovine albumin and polysorbate 80 Am. J. Vet. Res. 26 1965 45 -51
185.
Ellis W. A., Cassells J. A., and Doyle J. Genital leptospirosis in bulls Vet. Rec. 118 1986 333
186.
Ellis W. A., Hovind-Hougen K., Moller S., and Birch-Andresen A. Morphological changes upon subculturing of freshly isolated strains of Leptospira interrogans serovar hardjo Zentralbl. Bakteriol. Mikrobiol. Hyg. A 255 1983 323 -335
187.
Ellis W. A. and Michna S. W. Bovine leptospirosis: a serological and clinical study Vet. Rec. 99 1976 387 -391
188.
Ellis W. A. and Michna S. W. Bovine leptospirosis: demonstration of leptospires of the Hebdomadis serogroup in aborted fetuses and a premature calf Vet. Rec. 99 1976 430 -432
189.
Ellis W. A. and Michna S. W. Bovine leptospirosis: experimental infection of pregnant heifers with a strain belonging to the Hebdomadis serogroup Res. Vet. Sci. 22 1977 229 -236
190.
Ellis W. A. and Michna S. W. Bovine leptospirosis: infection by the Hebdomadis serogroup and abortion-a herd study Vet. Rec. 99 1976 409 -412
191.
Ellis W. A., Neill S. D., O'Brien J. J., Cassells J. A., and Hanna J. Bovine leptospirosis: microbiological and serological findings in normal fetuses removed from the uteri after slaughter Vet. Rec. 110 1982 192 -194
192.
Ellis W. A., O'Brien J. J., and Cassells J. Role of cattle in the maintenance of Leptospira interrogans serovar hardjo infection in Northern Ireland Vet. Rec. 108 2000 555 -557
193.
Ellis W. A., O'Brien J. J., Cassells J. A., Neill S. D., and Hanna J. Excretion of Leptospira interrogans serovar hardjo following calving or abortion Res. Vet. Sci. 39 1985 296 -298
194.
Ellis W. A., O'Brien J. J., Neill S., Hanna J., and Bryson D. G. The isolation of a leptospire from an aborted bovine fetus Vet. Rec. 99 1976 458 -459
195.
Ellis W. A., O'Brien J. J., Neill S. D., Ferguson H. W., and Hanna J. Bovine leptospirosis: microbiological and serological findings in aborted fetuses Vet. Rec. 110 1982 147 -150
196.
Ellis W. A., O'Brien J. J., Pearson J. K. L., and Collins D. S. Bovine leptospirosis: infection by the Hebdomadis serogroup and mastitis Vet. Rec. 99 1976 368 -370
197.
Ellis W. A., Songer J. G., Montgomery J., and Cassells J. A. Prevalence of Leptospira interrogans serovar hardjo in the genital and urinary tracts of non-pregnant cattle Vet. Rec. 118 1986 11 -13
198.
Ellis W. A. and Thiermann A. B. Isolation of leptospires from the genital tracts of Iowa cows Am. J. Vet. Res. 47 1986 1694 -1696
199.
Elwell M. R., Ward G. S., Hansukjariya P., and Tingpalapong M. Doxycycline prophylaxis for experimental leptospira infection in non-human primates and hamsters Southeast Asian J. Trop. Med. Public Health. 16 1985 268 -273
200.
Emmanouilides C. E., Kohn O. F., and Garibaldi R. Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome: case report Clin. Infect. Dis. 18 1994 1004 -1006
201.
Epstein P. R., Pena O. C., and Racedo J. B. Climate and disease in Colombia Lancet 346 1995 1243 -1244
202.
Estavoyer J.-M., Marquelet D., Baufle G.-H., Becque O., Michel-Briand Y., and Pageaut G. Leptospirose grave avec localisation cardiaque Presse Med. 9 1980 2579
203.
Estavoyer J. M., Racadot E., Couetdic G., Leroy J., and Grosperrin L. Tumor necrosis factor in patients with leptospirosis Rev. Infect. Dis. 13 1991 1245 -1246
204.
Evans, M., and G. Baranton. 2000. Leptospirosis outbreak in Eco Challenge 2000 participants, Eurosurveillance Weekly4:000921. [Online.]http://www.eurosurv.org/2000/000921.htm
205.
Everard C. O. R., Bennett S., Edwards C. N., Nicholson G. D., Hassell T. A., Carrington D. G., and Everard J. D. An investigation of some risk factors for severe leptospirosis on Barbados J. Trop. Med. Hyg. 95 1992 13 -32
206.
Everard C. O. R., Jones C. J., Inniss V. A., Carrington D. G., and Vaughan A. W. Leptospirosis in dogs on Barbados Isr. J. Vet. Med. 43 1987 288 -295
207.
Everard J. D. Leptospirosis The Wellcome Trust illustrated history of tropical diseases. The Wellcome Trust, London, U.K. Cox F. E. G. 1996 111–119, 416–418
208.
Everard J. D. and Everard C. O. R. Leptospirosis in the Caribbean Rev. Med. Microbiol. 4 1993 114 -122
209.
Faber N. A., Crawford M., LeFebvre R. B., Buyukmihci N. C., Madigan J. E., and Willits N. H. Detection of Leptospira spp. in the aqueous humor of horses with naturally acquired recurrent uveitis J. Clin. Microbiol. 38 2000 2731 -2733
210.
Faine S. Guidelines for the control of leptospirosis. 1982 World Health Organization Geneva, Switzerland
211.
Faine S. Leptospira and leptospirosis. 1994 CRC Press Boca Raton, Fla
212.
Faine S. Leptospirosis Laboratory diagnosis of infectious diseases: principles and practice Balows A., Hausler W. J., Ohashi M., and Turano A. 1 1988 344 -352 Springer-Verlag New York, N.Y
213.
Faine S., Adler B., Bolin C., and Perolat P. Leptospira and leptospirosis 2nd ed. 1999 MedSci Melbourne, Australia
214.
Faine S., Adler B., Christopher W., and Valentine R. Fatal congenital human leptospirosis Zentbl. Bakteriol. 257 1984 548
215.
Faine S., Adler B., and Palit A. Chemical, serological and biological properties of a serotype-specific polysaccharide antigen in Leptospira Aust. J. Exp. Biol. Med. Sci. 52 1974 311 -319
216.
Faine S., Adler B., and Ruta G. A mechanism of immunity to leptospirosis Aust. J. Exp. Biol. Med. Sci. 52 1974 301 -310
217.
Faine S. and Stallman N. D. Amended descriptions of the genus Leptospira Noguchi 1917 and the species L.interrogans (Stimson 1907) Wenyon 1926 and L. biflexa (Wolbach and Binger 1914) Noguchi 1918 Int. J. Syst. Bacteriol. 32 1982 461 -463
218.
Fairley N. H. Weil's disease among sewer workers in London BMJ 2 1934 10 -14
219.
Famatiga E. G., Topacio T. M., Suva M. H., and Oliveros F. M. Studies on leptospirosis in animals and man in the Philippines. V. Serological survey of leptospirosis among occupationally exposed Filipinos Southeast Asian J. Trop. Med. Public Health 3 1972 482 -488
220.
Feigin R. D. and Anderson D. C. Human leptospirosis Crit. Rev. Clin. Lab. Sci. 5 1975 413 -467
221.
Feigin R. D., Lobes L. A., Anderson D., and Pickering L. Human leptospirosis from immunized dogs Ann. Intern. Med. 79 1973 777 -785
222.
Feresu S. B., Bolin C. A., van de Kemp H., and Korver H. Identification of a serogroup Bataviae Leptospira strain isolated from an ox in Zimbabwe Zentralbl. Bakteriol. 289 1999 19 -29
223.
Feresu S. B., Steigerwalt A. G., and Brenner D. J. DNA relatedness of Leptospira strains isolated from beef cattle in Zimbabwe Int. J. Syst. Bacteriol. 49 1999 1111 -1117
224.
Forwell M. A., Redding P. G., Brodie M. J., and Gentleman D. de R. Leptospirosis complicated by fatal intracerebral haemorrhage BMJ 289 1984 1583
225.
Fraser D. W., Glosser J. W., Francis D. P., Phillips C. J., Feeley J. C., and Sulzer C. R. Leptospirosis caused by serotype fort-bragg—a suburban outbreak Ann. Intern. Med. 79 1973 786 -789
226.
French J. G. and Holt K. W. Floods The public health consequences of disasters. Gregg M. D. 1989 69 -78 Centers for Disease Control Atlanta, Ga
227.
Friedland J. S. and Warrell D. A. The Jarisch-Herxheimer reaction in leptospirosis: possible pathogenesis and review Rev. Infect. Dis. 13 1991 207 -210
228.
Fukunaga M., Horie I., Mifuchi I., and Takemoto M. Cloning, characterization and taxonomic significance of genes for the 5S ribosomal RNA of Leptonema illini strain 3055 J. Gen. Microbiol. 137 1991 1523 -1528
229.
Fukunaga M., Horie I., Okuzako N., and Mifuchi I. Nucleotide sequence of a 16S rRNA gene for Leptospira interrogans serovar canicola strain Moulton Nucleic Acids Res. 18 1990 366
230.
Fukunaga M. and Mifuchi I. The number of large ribosomal RNA genes in Leptospira interrogans and Leptospira biflexa Microbiol. Immunol. 33 1989 459 -466
231.
Fukunaga M. and Mifuchi I. Unique organization of Leptospira interrogans rRNA genes J. Bacteriol. 171 1989 5763 -5767
232.
Fuortes L. and Nettleman M. Leptospirosis: a consequence of the Iowa flood Iowa Med. 84 1994 449 -450
233.
Galli M., Esposito R., Crocchiolo P., Chemotti M., Gasparro M., and Dall'Aglio P. P. Immune complexes in leptospirosis Infection 13 1985 156
234.
Galton M. M., Powers D. K., Hall A. M., and Cornell R. G. A rapid microscopic-slide screening test for the serodiagnosis of leptospirosis Am. J. Vet. Res. 19 1958 505 -512
235.
Galton M. M., Sulzer C. R., Santa Rosa C. A., and Fields M. J. Application of a microtechnique to the agglutination test for leptospiral antibodies Appl. Microbiol. 13 1965 81 -85
236.
Gauld R. L., Crouch W. L., Kaminsky A. L., Hullinghorst R. L., Gochenour W. S., and Yager R. H. Leptospiral meningitis: report of an outbreak among American troops on Okinawa JAMA 149 1952 228 -231
237.
Gerritsen M. A., Smits M. A., and Olyhoek T. Random amplified polymorphic DNA fingerprinting for rapid identification of leptospiras of serogroup Sejroe J. Med. Microbiol. 42 1995 336 -339
238.
Giles N., Hathaway S. C., and Stevens A. E. Isolation of Leptospira interrogans serovar hardjo from a viable premature calf Vet. Rec. 113 1983 174 -176
239.
Gilks C. F., Lambert H. P., Broughton E. S., and Baker C. C. Failure of penicillin prophylaxis in laboratory acquired leptospirosis Postgrad. Med. J. 64 1988 236 -238
240.
Gill N., Waitkins S. A., and Calder I. M. Further update on leptospirosis: continuing risk in fish farmers BMJ 290 1985 1988
241.
Gill O. N., Coghlan J. D., and Calder I. M. The risk of leptospirosis in United Kingdom fish farm workers J. Hyg. 94 1985 81 -86
242.
Gillespie R. W. H. and Ryno J. Epidemiology of leptospirosis Am. J. Public Health 53 1963 950 -955
243.
Gochenour W. S., Gleiser C. A., and Ward N. K. Laboratory diagnosis of leptospirosis Ann. N.Y. Acad. Sci. 70 1958 421 -426
244.
Gollop J. H., Katz A. R., Rudoy R. C., and Sasaki D. M. Rat-bite leptospirosis West. J. Med. 159 1993 76 -77
245.
Gonsalez C. R., Casseb J., Monteiro F. G., Paula-Neto J. B., Fernandez R. B., Silva M. B., Camargo E. D., Mairinque J. M., and Tavares L. C. Use of doxycycline for leptospirosis after high-risk exposure in Sao Paulo, Brazil Rev. Inst. Med. Trop. Sao Paulo 41 1998 59 -61
246.
Gordon Smith C. E. and Turner L. H. The effect of pH on the survival of leptospires in water Bull. WHO 24 1961 35 -43
247.
Gravekamp C., van de Kemp H., Carrington D., van Eys G. J. J. M., Everard C. O. R., and Terpstra W. J. Detection of leptospiral DNA by PCR in serum from patients with copenhageni infections Leptospirosis. Proceedings of the Leptospirosis Research Conference 1990. Kobayashi Y. 1991 151 -164 University of Tokyo Press Tokyo, Japan
248.
Gravekamp C., van de Kemp H., Franzen M., Carrington D., Schoone G. J., van Eys G. J. J. M., Everard C. O. R., Hartskeerl R. A., and Terpstra W. J. Detection of seven species of pathogenic leptospires by PCR using two sets of primers J. Gen. Microbiol. 139 1993 1691 -1700
249.
Grégoire N., Higgins R., and Robinson Y. Isolation of leptospires from nephritic kidneys of beef cattle at slaughter Am. J. Vet. Res. 48 1987 370 -371
250.
Grell G., Ho-Ping-Kong H., Ragbeer M. M. S., Barrow O., Ward E. E., and Alleyne G. A. O. Peritoneal dialysis in severe leptospiral renal failure West Indian Med. J. 20 1971 76 -82
251.
Guidugli F., Castro A. A., and Atallah A. N. Antibiotics for preventing leptospirosis (Cochrane Review), Cochrane Library, issue 4. 2000 Update Software Oxford, U.K
252.
Guidugli F., Castro A. A., and Atallah A. N. Antibiotics for treating leptospirosis (Cochrane Review), Cochrane Library, Issue 2. 2000 Update Software Oxford, U.K
253.
Gussenhoven G. C., van der Hoorn M. A. W. G., Goris M. G. A., Terpstra W. J., Hartskeerl R. A., Mol B. W., van Ingen C. W., and Smits H. L. LEPTO dipstick, a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human sera J. Clin. Microbiol. 35 1997 92 -97
254.
Haake D. A. Spirochaetal lipoproteins and pathogenesis Microbiology 146 2000 1491 -1504
255.
Haake D. A., Champion C. I., Martinich C., Shang E. S., Blanco D. R., Miller J. N., and Lovett M. A. Molecular cloning and sequence analysis of the gene encoding OmpL1, a transmembrane outer membrane protein of pathogenic Leptospira spp J. Bacteriol. 175 1993 4225 -4234
256.
Haake D. A., Chao G., Zuerner R. L., Barnett J. K., Barnett D., Mazel M., Matsunaga J., Levett P. N., and Bolin C. A. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection Infect. Immun. 68 2000 2276 -2285
257.
Haake D. A., Martinich C., Summers T. A., Shang E. S., Pruetz J. D., McCoy A. M., Mazel M. K., and Bolin C. A. Characterization of leptospiral outer membrane lipoprotein LipL36: downregulation associated with late-log-phase growth and mammalian infection Infect. Immun. 66 1998 1579 -1587
258.
Haake D. A., Mazel M. K., McCoy A. M., Milward F., Chao G., Matsunaga J., and Wagar E. A. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection Infect. Immun. 67 1999 6572 -6582
259.
Haake D. A., Walker E. M., Blanco D. R., Bolin C. A., Miller M. N., and Lovett M. A. Changes in the surface of Leptospira interrogans serovar grippotyphosa during in vitro cultivation Infect. Immun. 59 1991 1131 -1140
260.
Haapala D. K., Rogul M., Evans L. B., and Alexander A. D. Deoxyribonucleic acid base composition and homology studies of Leptospira J. Bacteriol. 98 1969 421 -428
261.
Harkin K. R. and Gartrell C. L. Canine leptospirosis in New Jersey and Michigan: 17 cases (1990–1995) J. Am. Anim. Hosp. Assoc. 32 1996 495 -501
262.
Harrison N. A. and Fitzgerald W. R. Leptospirosis—can it be a sexually transmitted disease? Postgrad. Med. J. 64 1988 163 -164
263.
Hart R. J. C., Gallagher J., and Waitkins S. An outbreak of leptospirosis in cattle and man BMJ 288 1984 1983 -1984
264.
Hartman E. G. An IgM- and IgG-specific enzyme-linked immunosorbent assay (ELISA) to detect anti-leptospiral immunoglobulins in dogs Zentbl. Bakteriol. 257 1984 508 -510
265.
Hartman E. G., Van Houten M., Van der Donk J. A., and Frik J. F. Serodiagnosis of canine leptospirosis by solid-phase enzyme-linked immunosorbent assay Vet. Immunol. Immunopathol. 7 1984 33 -42
266.
Hartskeerl R. A. and Terpstra W. J. Leptospirosis in wild animals Vet. Q. 18 (Suppl. 3) 1996 S149 -S150
267.
Hathaway S. C., Little T. W. A., and Pritchard D. G. Problems associated with the serological diagnosis of Leptospira interrogans serovar hardjo infection in bovine populations Vet. Rec. 119 1986 84 -86
268.
Hathaway S. C., Little T. W. A., and Stevens A. E. Isolation of Leptospira interrogans serovar hardjo from aborted bovine fetuses in England Vet. Rec. 111 1982 58
269.
Hathaway S. C., Marshall R. B., Little T. W. A., Headlam S. A., and Winter P. J. Differentiation of reference strains of leptospires of the Pomona serogroup by cross-agglutination absorption and restriction endonuclease analysis Res. Vet. Sci. 39 1985 145 -150
270.
Hathaway S. C., Marshall R. B., Little T. W. A., Headlam S. A., and Winter P. J. Identification by cross-agglutination absorption and restriction endonuclease analysis of leptospires of the Pomona serogroup isolated in the United Kingdom Res. Vet. Sci. 39 1985 151 -156
271.
Haunz E. A. and Cardy J. D. Canicola fever: report of nine cases in one family, with abstract of the world literature Arch. Intern. Med. 89 1952 978 -993
272.
Havens W. P., Bucher C. J., and Reimann H. A. Leptospirosis: a public health hazard. Report of a small outbreak of Weil's disease in bathers JAMA 116 1941 289 -291
273.
Heath C. W., Alexander A. D., and Galton M. M. Leptospirosis in the United States: 1949–1961 N. Engl. J. Med. 273 1965 857–864, 915–922.
274.
Hellstrom J. S. and Marshall R. B. Survival of Leptospira interrogans serovar pomona in an acidic soil under simulated New Zealand field conditions Res. Vet. Sci. 25 1978 29 -33
275.
Henry R. A., Johnson R. C., Bohlool B. B., and Schmidt E. L. Detection of Leptospira in soil and water by immunofluorescence staining Appl. Microbiol. 21 1971 953 -956
276.
Hergt R. Meaning of serotype Patoc (biflexa complex) for the diagnosis of leptospirosis by microscopic agglutination test Zentbl. Bakteriol. 235 1976 506 -511
277.
Hernandez M. S., Aguila J. B., Gonzalez L. P., and Gonzalez V. G. Brote de leptospirosis en niños con predomino meningoencefálico, en el municipio Morón Rev. Cuba. Med. Trop. 43 1991 136 -139
278.
Heron L. G., Reiss-Levy E. A., Jacques T. C., Dickeson D. J., Smythe L. D., and Sorrell T. C. Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa Med. J. Aust. 167 1997 477 -479
279.
Herrmann J. L. Genomic techniques for identification of Leptospira strains Pathol. Biol. 41 1993 943 -950
280.
Herrmann J. L., Bakoss P., Korver H., Bulu A. A., Bellenger E., Terpstra W. J., Saint Girons I., and Baranton G. A new serovar in the Grippotyphosa serogroup comprising leptospiral isolates from different regions Int. J. Syst. Bacteriol. 44 1994 362 -364
281.
Herrmann J. L., Baril C., Bellenger E., Perolat P., Baranton G., and Saint Girons I. Genome conservation in isolates of Leptospira interrogans J. Bacteriol. 173 1991 7582 -7588
282.
Herrmann J. L., Bellenger E., Perolat P., Baranton G., and Saint Girons I. Pulsed-field gel electrophoresis of NotI digests of leptospiral DNA: a new rapid method of serovar identification J. Clin. Microbiol. 30 1992 1696 -1702
283.
Hill M. K. and Sanders C. V. Leptospiral pneumonia Semin. Respir. Infect. 12 1997 44 -49
284.
Hodges R. T. and Ekdahl M. O. Use of a fluorescent antibody technique for the serological differentiation of leptospiral serotypes in cultures and in bovine urine N. Z. Vet. J. 21 1973 109 -115
285.
Hoghton M. A. R. and Proce P. A. Leptospirosis hardjo epididymitis BMJ 292 1986 174
286.
Hookey J. V. Characterization of Leptospiraceae by 16S DNA restriction length polymorphisms J. Gen. Microbiol. 139 1993 1681 -1689
287.
Hookey J. V. Detection of Leptospiraceae by amplification of 16S ribosomal DNA FEMS Microbiol. Lett. 90 1992 267 -274
288.
Hookey J. V. and Palmer M. F. A comparative investigation and identification of Leptospira interrogans serogroup icterohaemorrhagiae strains by monoclonal antibody and DNA fingerprint analysis Zentbl. Bakteriol. 275 1991 185 -199
289.
Hübener E. A. and Reiter H. Beiträge zur Aetiologie der Weilschen Krankheit Dtsch. Med. Wochenschr. 41 1915 1275 -1277
290.
Hudson C. P., Levett P. N., Edwards C. N., Moosai R., and Roach T. C. Severe primary HIV-1 infection among black persons in Barbados Int. J. STD AIDS 8 1997 393 -397
291.
Humphry T., Sanders S., and Stadius M. Leptospirosis mimicking MLNS J. Pediatr. 91 1977 853 -854
292.
Hyde F. W. and Johnson R. C. Genetic relationship of lyme disease spirochetes to Borrelia, Treponema, and Leptospira spp J. Clin. Microbiol. 20 1984 151 -154
293.
Ido Y., Hoki R., Ito H., and Wani H. The rat as a carrier of Spirochaeta icterohaemorrhagiae, the causative agent of Weil's disease (spirochaetosis icterohaemorrhagica) J. Exp. Med. 26 1917 341 -353
294.
Im J.-G., Yeon K. M., Han M. C., Kim C.-W., Webb W. R., Lee J. S., Han Y. C., Chang W. H., and Chi J. G. Leptospirosis of the lung: radiographic findings in 58 patients Am. J. Roentgenol. 152 1989 955 -959
295.
Imamura S., Matsui H., and Ashizawa Y. Indirect hemagglutination test for detection of leptospiral antibodies Jpn. J. Exp. Med. 44 1974 191 -197
296.
Inada R., Ido Y., Hoki R., Kaneko R., and Ito H. The etiology, mode of infection, and specific therapy of Weil's disease (spirochaetosis icterohaemorrhagica) J. Exp. Med. 23 1916 377 -402
297.
International Committee on Systematic Bacteriology Subcommittee on the Taxonomy of Leptospira Minutes of the meeting, 5 and 6 September 1986, Manchester, England Int. J. Syst. Bacteriol. 37 1987 472 -473
298.
Isogai E., Hirose K., Kimura K., Hayashi S., Kubota T., Fujii N., and Isogai H. Role of platelet-activating-factor (PAF) on cellular responses after stimulation with leptospire lipopolysaccharide Microbiol. Immunol. 41 1997 271 -275
299.
Isogai E., Isogai H., Kubota T., Fujii N., Hayashi S., Indoh T., Takagi S., Miura H., and Kimura K. Apoptosis of lymphocytes in mice administered lipopolysaccharide from Leptospira interrogans Zentbl. Vetmed. Reihe B 45 1998 529 -537
300.
Isogai E., Isogai H., Kurebayashi Y., and Ito N. Biological activities of leptospiral lipopolysaccharide Zentbl. Bakteriol. 261 1986 53 -64
301.
Isogai E., Kitagawa H., Isogai H., Kurebayashi Y., and Ito N. Phagocytosis as a defense mechanism against infection with leptospiras Zentbl. Bakteriol. 261 1986 65 -74
302.
Jackson L. A., Kaufmann A. F., Adams W. G., Phelps M. B., Andreasen C., Langkop C. W., Francis B. J., and Wenger J. D. Outbreak of leptospirosis associated with swimming Pediatr. Infect. Dis. J. 12 1993 48 -54
303.
Jeandel P., Raoult D., Rougier Y., Auger C., and Mailloux M. Late positive blood cultures in leptospiroses (report of four cases) Trans. R. Soc. Trop. Med. Hyg. 78 1984 143 -145
304.
Jellison W. L., Stoenner H. G., and Berg G. M. Leptospirosis among Indians in the Dakotas Rocky Mt. Med. J. 55 1958 56–58, 121.
305.
Jerrett I. V., McOrist S., Waddington J., Browning J. W., Malecki J. C., and McCausland I. P. Diagnostic studies of the fetus, placenta and maternal blood from 265 bovine abortions Cornell Vet. 74 1984 8 -20
306.
Jevon T. R., Knudson M. P., Smith P. A., Whitecar P. S., and Blake R. L. A point-source epidemic of leptospirosis: description of cases, cause, and prevention Postgrad. Med. 80 1986 121 -129
307.
Johnson D. W. The Australian leptospiroses Med. J. Aust. 2 1950 724 -731
308.
Johnson D. W., Brown H. E., and Derrick E. H. Weil's disease in Brisbane Med. J. Aust. 1 1937 811 -818
309.
Johnson R. C. and Faine S. Leptospira Bergey's manual of systematic bacteriology Krieg N. R. and Holt J. G. 1 1984 62 -67 Williams & Wilkins Baltimore, Md
310.
Johnson R. C. and Harris V. G. Differentiation of pathogenic and saprophytic leptospires. 1. Growth at low temperatures J. Bacteriol. 94 1967 27 -31
311.
Johnson R. C. and Rogers P. 5-Fluorouracil as a selective agent for growth of leptospirae J. Bacteriol. 87 1964 422 -426
312.
Johnson R. C., Walby J., Henry R. A., and Auran N. E. Cultivation of parasitic leptospires: effect of pyruvate Appl. Microbiol. 26 1973 118 -119
313.
Johnson W. D., Silva I. C., and Rocha H. Serum creatinine phosphokinase in leptospirosis JAMA 233 1975 981 -982
314.
Johnston J. H., Lloyd J., McDonald J., and Waitkins S. Leptospirosis-an occupational disease of soldiers J. R. Army Med. Corps 129 1983 111 -114
315.
Jorge R. Une epidemie, a Lisbonne, d'ictere hemorragique d'origine hydrique contracte per os: nosologie, bacteriologie et epidemiologie Bull. Off. Int. Hyg. Publique 24 1932 88 -117
316.
Jost B. H., Adler B., Vinh T., and Faine S. A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis J. Med. Microbiol. 22 1986 269 -275
317.
Kalambaheti T., Bulach D. M., Rajakumar K., and Adler B. Genetic organization of the lipopolysaccharide O-antigen biosynthetic locus of Leptospira borgpetersenii serovar Hardjobovis Microb. Pathog. 27 1999 105 -117
318.
Kalsow C. M. and Dwyer A. E. Retinal immunopathology in horses with uveitis Ocul. Immunol. Inflamm. 6 1998 239 -251
319.
Karaseva E. V., Chernukha Y. G., and Piskunova L. A. Results of studying the time of survival of pathogenic leptospira under natural conditions J. Hyg. Epidemiol. Microbiol. Immunol. 17 1973 339 -345
320.
Katz A. R., Manea S. J., and Sasaki D. M. Leptospirosis on Kauai: investigation of a common source waterborne outbreak Am. J. Public Health 81 1991 1310 -1312
321.
Katz A. R., Sasaki D. M., Mumm A. H., Escamilla J., Middleton C. R., and Romero S. E. Leptospirosis on Oahu: an outbreak among military personnel associated with recreational exposure Mil. Med. 162 1997 101 -104
322.
Kaufmann A. F. and Weyant R. S. Leptospiraceae Manual of clinical microbiology 6th ed. Murray P. R. et al. 1995 621 -625 ASM Press Washington, D.C.
323.
Kawaoka Y., Naiki M., and Yanagawa R. Radioimmunoassay system using a serovar-specific lipopolysaccharide antigen of Leptospira J. Clin. Microbiol. 10 1979 313 -316
324.
Kee S. H., Kim I. K., Choi M. S., and Chang W. H. Detection of leptospiral DNA by PCR J. Clin. Microbiol. 32 1994 1035 -1039
325.
Kelley P. W. Leptospirosis Infectious diseases 2nd ed. Gorbach S. L., Bartlett J. G., and Blacklow N. R. 1998 1580 -1587 W. B. Saunders Philadelphia, Pa
326.
Kida H., Watanabe H., Yamamoto S., and Yanagawa R. Immunological and morphological analysis of sodium dodecyl sulfate extract of Leptospira Zentbl. Bakteriol. 236 1976 328 -335
327.
Kim M. J. Serovar identification of Korean leptospiral strains with monoclonal antibodies Korean J. Intern. Med. 32 1987 571 -578
328.
King S. D. and Urquhart A. E. Laboratory investigations on four cases of leptospiral meningitis in Jamaica West Indian Med. J. 24 1975 196 -201
329.
Klarenbeek A. and Schüffner W. A. P. Het voorkomen van een afwijkend leptospira-ras in Nederland Ned. Tijdschr. Geneeskd. 77 1933 4271 -4276
330.
Kmety E. and Dikken H. Classification of the species Leptospira interrogans and history of its serovars. 1993 University Press Groningen Groningen, The Netherlands
331.
Knight L. L., Miller N. G., and White R. J. Cytotoxic factor in the blood and plasma of animals during leptospirosis Infect. Immun. 8 1973 401 -405
332.
Ko A. I., Galvao Reis M., Ribeiro Dourado C. M., Johnson W. D., Riley L. W., and the Salvador Leptospirosis Study Group Urban epidemic of severe leptospirosis in Brazil Lancet 354 1999 820 -825
333.
Kobayashi Y., Tamai T., and Sada E. Serological analysis of serogroup lcterohaemorrhagiae using monoclonal antibodies Microbiol. Immunol. 29 1985 1229 -1235
334.
Korver H., Kolk A. H. J., Vingerhoed J., van Leeuwen J., and Terpstra W. J. Classification of serovars of the lcterohaemorrhagiae serogroup by monoclonal antibodies Isr. J. Vet. Med. 44 1988 15 -18
335.
Kramer K. J., Pang L. W., Minette H. P., and Perrone J. B. Evaluation of the quantitative buffy coat analysis (QBC) system for the detection of leptosira in human blood Southeast. Asian J. Trop. Med. Public Health 25 1994 788 -789
336.
Laing R. W., Teh C., and Toh C. H. Thrombotic thrombocytopenic purpura (TTP) complicating leptospirosis: a previously undescribed phenomenon J. Clin. Pathol. 43 1990 961 -962
337.
Landouzy L. T. J. Fièvre bilieuse ou hépatique Gaz. Hôpital 56 1883 809
338.
Landouzy L. T. J. Typhus hépatique Gaz. Hôpital 56 1883 913
339.
Law-Koune J. D., Picard P., Van Der Linden T., Michault A., Corbin J. C., and Duval G. Thrombocytopenia in leptospirosis: role of anti-platelet antibodies Presse Med. 17 1988 1315 -1316
340.
Lederberg J., Shope R. E., and Oaks S. C. Emerging infections: microbial threats to health in the United States. 1992 National Academy Press Washington, D.C.
341.
Lee M. G., Char G., Dianzumba S., and Prussia P. Cardiac involvement in severe leptospirosis West Indian Med. J. 35 1986 295 -300
342.
Lee R. E. J., Terry S. I., Walker T. M., and Urquhart A. E. The chest radiograph in leptospirosis in Jamaica Br. J. Radiol. 54 1981 939 -943
343.
Lee S. H., Kim K. A., Park Y. G., Seong I. W., Kim M. J., and Lee Y. J. Identification and partial characterization of a novel hemolysin from Leptospira interrogans serovar lai Gene 254 2000 19 -28
344.
LeFebvre R. B. DNA probe for detection of the Leptospira interrogans serovar hardjo genotype hardjo-bovis J. Clin. Microbiol. 25 1987 2236 -2238
345.
LeFebvre R. B., Thiermann A. B., and Foley J. Genetic and antigenic differences of serologically indistinguishable leptospires of serovar hardjo J. Clin. Microbiol. 25 1987 2094 -2097
346.
Lessa I. and Cortes E. Cerebrovascular accident as a complication of leptospirosis Lancet ii 1981 1113
347.
Letocart M., Baranton G., and Perolat P. Rapid identification of pathogenic Leptospira species (Leptospira interrogans, L. borgpetersenii, and L. kirschneri) with species-specific DNA probes produced by arbitrarily primed PCR J. Clin. Microbiol. 35 1997 248 -253
348.
Letocart M., Boerlin P., Boerlin-Petzold F., Goudet J., Baranton G., and Perolat P. Genetic structure of the genus Leptospira by mutlilocus enzyme electrophoresis Int. J. Syst. Bacteriol. 49 1999 231 -238
349.
Levett P. N. Leptospirosis: re-emerging or re-discovered disease? J. Med. Microbiol. 48 1999 417 -418
350.
Levett P. N., Branch S. L., and Edwards C. N. Detection of dengue infection in patients investigated for leptospirosis in Barbados Am. J. Trop. Med. Hyg. 62 2000 112 -114
350a.
Levett P. N., Branch S. L., Whittington C. U., Edwards C. N., and Paxton H. Two methods for rapid serological diagnosis of acute leptospirosis Clin. Diagn. Lab. Immunol. 8 2001 349 -351
351.
Levett P. N. and Whittington C. U. Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis J. Clin. Microbiol. 36 1998 11 -14
352.
Levine D. F. Leptospirosis in the milking parlour Br. J. Hosp. Med. 42 1989 340
353.
Lin C., Ma T., Ch'en Y. C., and Cheng W. Studies on anicteric leptospirosis. II. Observations on electrocardiograms Chin. Med. J. 84 1965 291 -298
354.
Lin M., Bughio N., and Surujballi O. Expression in Escherichia coli of flaB, the gene coding for a periplasmic flagellin of Leptospira interrogans serovar pomona J. Med. Microbiol. 48 1999 977 -982
355.
Lin M., Surujballi O., Nielsen K., Nadin-Davis S., and Randall G. Identification of a 35-kilodalton serovar-cross-reactive flagellar protein, FlaB, from Leptospira interrogans by N-terminal sequencing, gene cloning, and sequence analysis Infect. Immun. 65 1997 4355 -4359
356.
Lindsay S. and Luke I. W. Fatal leptospirosis (Weil's disease) in a newborn infant. Case of intrauterine fetal infection with report of an autopsy J. Pediatr. 34 1949 90 -94
357.
Looke D. F. M. Weil's syndrome in a zoologist Med. J. Aust. 144 1986 597 -601
358.
Lucchesi P. M. and Parma A. E. A DNA fragment of Leptospira interrogans encodes a protein which shares epitopes with equine cornea Vet. Immunol. Immunopathol. 71 1999 173 -179
359.
Lupidi R., Cinco M., Balanzin D., Delprete E., and Varaldo P. E. Serological follow-up of patients in a localized outbreak of leptospirosis J. Clin. Microbiol. 29 1991 805 -809
360.
Luzzi G. A., Milne L. M., and Waitkins S. A. Rat-bite acquired leptospirosis J. Infect. 15 1987 57 -60
361.
Mackenzie R. B., Reiley C. G., Alexander A. G., Bruckner E. A., Diercks F. H., and Beye H. K. An outbreak of leptospirosis among U.S. army troops in the Canal Zone. I. Clinical and laboratory observations Am. J. Trop. Med. Hyg. 15 1966 57 -63
362.
Mailloux M. Use of the Leptospira biflexa Patoc antigen in the serodiagnosis of leptospirosis Ann. Inst. Pasteur 112 1967 121 -125
363.
Mailloux M., Dufresne Y., Mazzonelli J., and Dorta de Mazzonelli G. T. Intérêt de la méthode ELISA dans le diagnostic des leptospiroses Med. Mal. Infect. 14 1984 107 -109
364.
Mailloux M., Mazzonelli J., and Dorta de Mazzonelli G. T. Thermoresistant antigen in leptospires. Possibility of a macroscopic diagnosis of leptospirosis with a single antigen Zentbl. Bakteriol. Mikrobiol. Hyg. A 229 1974 238 -241
365.
Mailloux M., Mazzonelli J. G., and Dufresne Y. Application of an immuno-enzyme technique to titration of antibodies in leptospirosis: ELISA (enzyme-linked immunosorbent assay) Zentbl. Bakteriol. 257 1984 511 -513
366.
Manca N., Verardi R., Colombrita D., Ravizzola G., Savoldi E., and Turano A. Radiometric method for the rapid detection of Leptospira organisms J. Clin. Microbiol. 23 1986 401 -403
367.
Mancel E., Merien F., Pesenti L., Salino D., Angibaud G., and Perolat P. Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific) Aust. N. Z. J. Ophthalmol. 27 1999 380 -386
368.
Manev C. Serological characteristics of the leptospira serogroup Pomona. II Changes in the agglutination and absorption properties of the reference strain after formalin- and heat-inactivation Zentbl. Bakteriol. 236 1976 323 -327
369.
Marı́n-Léon I., Pérez-Lozano M. J., de Villar-Conde E., Dastis-Bendala C., Vargas-Romero J., and Pumarola-Suñé T. Prospective evaluation of the macroagglutination slide test for Leptospira Serodiagn. Immunother. Infect. Dis. 8 1997 191 -193
370.
Marshall R. B., Wilton B. E., and Robinson A. J. Identification of Leptospira serovars by restriction-endonuclease analysis J. Med. Microbiol. 14 1981 163 -166
371.
Marshall R. B., Winter P. J., Thiermann A. B., and Ellis W. A. Genotypes of Leptospira interrogans serovar hardjo in cattle in the UK Vet. Rec. 117 1985 669 -670
372.
Marshall R. B., Winter P. J., and Yanagawa R. Restriction endonuclease DNA analysis of Leptospira interrogans serovars icterohaemorrhagiae and hebdomadis J. Clin. Microbiol. 20 1984 808 -810
373.
Martin L. and Pettit A. Sero-diagnostic de la spirochaetose icterohaemorrhagique Bull. Mem. Soc. Med. Hop. Paris 42 1918 672 -675
374.
Martinelli R., Luna M. A., and Rocha H. Is rhabdomyolysis an additonal factor in the pathogenesis of acute renal failure in leptospirosis? Rev. Inst. Med. Trop. Sao Paulo 36 1994 111 -114
375.
Martı́nez Garcı́a M. A., de Diego Damiá A., Menéndez Villanueva R., and López Hontagas J. L. Pulmonary involvement in leptospirosis Eur. J. Clin. Microbiol. Infect. Dis. 19 2000 471 -474
376.
Martinez Sanchez R., Obregon Fuentes A. M., Perez Sierra A., Baly Gil A., Diaz Gonzalez M., Baro Suarez M., Menendez Capote R., Ruiz Perez A., Sierra Gonzalez G., and Lopez Chavez A. U. The reactogenicity and immunogenicity of the first Cuban vaccine against human leptospirosis Rev. Cuba. Med. Trop. 50 1998 159 -166
377.
Martins M. G., Matos K. T., da Silva M. V., and de Abreu M. T. Ocular manifestations in the acute phase of leptospirosis Ocul. Immunol. Inflamm. 6 1998 75 -79
378.
Masri S. A., Nguyen P. T., Gale S. P., Howard C. J., and Jung S. C. A polymerase chain reaction assay for the detection of Leptospira spp. in bovine semen Can. J. Vet. Res. 61 1997 15 -20
379.
Masuzawa T., Nakamura R., Shimizu T., and Yanagihara Y. Biological activities and endotoxic activities of protective antigens (PAgs) of Leptospira interrogans Zentbl. Bakteriol. 274 1990 109 -117
380.
Matthias M. A. Molecular characterization of pathogenic Leptospira from animals on the island of Barbados. Ph.D. thesis. 2000 University of the West Indies Barbados
381.
Mazzonelli J., Dorta de Mazzonelli G., and Mailloux M. Possibilité de diagnostique sérologique macroscopique des leptospires à l'aide d'un antigene unique Med. Mal. Infect. 4 1974 253 -254
382.
McClain J. B. L., Ballou W. R., Harrison S. M., and Steinweg D. L. Doxycycline therapy for leptospirosis Ann. Intern. Med. 100 1984 696 -698
383.
McComb D. E., Smith D. J. W., Coffin D. L., MacCready R. A., and Chang R. S. The use of erythrocyte sensitizing substance in the diagnosis of leptospirosis. I. The sensitized erythrocyte agglutination test Am. J. Trop. Med. Hyg. 6 1957 90 -100
384.
McCrumb F. R., Stockard J. L., Robinson C. R., Turner L. H., Levis D. G., Maisey C. W., Kelleher M. F., Gleiser C. A., and Smadel J. E. Leptospirosis in Malaya. I. Sporadic cases among military and civilian personnel Am. J. Trop. Med. Hyg. 6 1957 238 -256
385.
McGrath H., Adler B., Vinh T., and Faine S. Phagocytosis of virulent and avirulent leptospires by guinea-pig and human polymorphonuclear leukocytes in vitro Pathology 16 1984 243 -249
386.
Merien F., Amouriauz P., Perolat P., Baranton G., and Saint Girons I. Polymerase chain reaction for detection of Leptospira spp. in clinical samples J. Clin. Microbiol. 30 1992 2219 -2224
387.
Merien F., Baranton G., and Perolat P. Comparison of polymerase chain reaction with microagglutination test and culture for diagnosis of leptospirosis J. Infect. Dis. 172 1995 281 -285
388.
Merien F., Baranton G., and Perolat P. Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence Infect. Immun. 65 1997 729 -738
389.
Merien F., Perolat P., Mancel E., Persan D., and Baranton G. Detection of leptospiral DNA by polymerase chain reaction in aqueous humor of a patient with unilateral uveitis J. Infect. Dis. 168 1993 1335 -1336
390.
Merien F., Truccolo J., Baranton G., and Perolat P. Identification of a 36-kDa fibronectin-binding protein expressed by a virulent variant of Leptospira interrogans serovar icterohaemorrhagiae FEMS Microbiol. Lett. 185 2000 17 -22
391.
Merien F., Truccolo J., Rougier Y., Baranton G., and Perolat P. In vivo apoptosis of hepatocytes in guinea pigs infected with Leptospira interrogans serovar icterohaemorrhagiae FEMS Microbiol. Lett. 169 1998 95 -102
392.
Midwinter A., Vinh T., Faine S., and Adler B. Characterization of an antigenic oligosaccharide from Leptospira interrogans serovar pomona and its role in immunity Infect. Immun. 62 1994 5477 -5482
393.
Millar B. D., Chappel R. J., and Adler B. Detection of leptospires in biological fluids using DNA hybridization Vet. Microbiol. 15 1987 71 -78
394.
Miller N. G., Froehling R. C., and White R. J. Activity of leptospires and their products on L cell monolayers Am. J. Vet. Res. 31 1970 371 -377
395.
Milner A. R., Jackson K. B., Woodruff K., and Smart I. J. Enzyme-linked immunosorbent assay for determining specific immunoglobulin M in infections caused by Leptospira interrogans serovar hardjo J. Clin. Microbiol. 22 1985 539 -542
396.
Misao T., Hiroyoshi S., Katsuta K., Nishihara Y., Kobayashi Y., Kuwashima K., and Aso M. Canicola fever in Japan Am. J. Hyg. 63 1956 294 -307
397.
Mitchison M., Bulach D. M., Vinh T., Rajakumar K., Faine S., and Adler B. Identification and characterization of the dTDP-rhamnose biosynthesis and transfer genes of the lipopolysaccharide-related rfb locus in Leptospira interrogans serovar copenhageni J. Bacteriol. 179 1997 1262 -1267
398.
Mitchison M., Rood J. I., Faine S., and Adler B. Molecular analysis of a Leptospira borgpetersenii gene encoding an endoflagellar subunit protein J. Gen. Microbiol. 137 1991 1529 -1536
399.
Mohammedi I., Chaumentin G., Sab J. M., Dubois J. M., Mignot F., and Robert D. Syndrome de détresse respiratoire aiguë par hémorragie intra-alvéolaire au cours d'une leptospirose Presse Med. 22 1993 1148 -1149
400.
Mollaret P. and Ferroir J. Two cases of icterohemorrhagic spirochetosis, one with fatal myocarditis; contribution to the study of meningeal reactions of typical icterogenic forms of spirochetosis Bull. Mem. Soc. Med. Hop. Paris 51 1935 1622 -1632
401.
Monno S. and Mizushima Y. Leptospirosis with acute acalculous cholecystitis and pancreatitis J. Clin. Gastroenterol. 16 1993 52 -54
402.
Monsuez J.-J., Kidouche R., Le Gueno B., and Postic D. Leptospirosis presenting as haemorrhagic fever in visitor to Africa Lancet 349 1997 254 -255
403.
Morgan A. G. and Cawich F. Ascending polyneuropathy in leptospirosis-a case study Ann. Trop. Med. Parasitol. 74 1980 567 -568
404.
Morris J. A. and Hussaini S. N. Characterization of the antibodies detected by the microscopic agglutination test for bovine leptospirosis J. Hyg. 73 1974 425 -432
405.
Mumford C. J. Leptospirosis and water sports Br. J. Hosp. Med. 41 1989 519
406.
Murgatroyd F. Chronic meningitis in Weil's disease BMJ 1 1937 7 -11
407.
Murgia R., Riquelme N., Baranton G., and Cinco M. Oligonucleotides specific for pathogenic and saprophytic leptospira occurring in water FEMS Microbiol. Lett. 148 1997 27 -34
408.
Muthusethupati M. A. and Shivakumar S. Acute renal failure due to leptospirosis J. Assoc. Phys. India 35 1987 631 -633
409.
Myers D. M. Effect of culture medium on the agglutinability of leptospires by the microscopic agglutination test Rev. Argent. Microbiol. 8 1976 14 -20
410.
Myers D. M. Serodiagnosis of human leptospirosis by counterimmunoelectrophoresis J. Clin. Microbiol. 25 1987 897 -899
411.
Myers D. M. and Coltorti E. A. Broadly reacting precipitating and agglutinating antigen of leptospirae J. Clin. Microbiol. 8 1978 580 -590
412.
Myers D. M. and Jelambi F. Isolation and identification of Leptospira hardjo from cattle in Argentina Trop. Geogr. Med. 27 1975 63 -70
413.
Myers D. M. and Varela-Diaz V. M. Selective isolation of leptospiras from contaminated material by incorporation of neomycin to culture media Appl. Microbiol. 25 1973 781 -786
414.
Nelson K. E., Ager E. A., Galton M. M., Gillespie R. W. H., and Sulzer C. R. An outbreak of leptospirosis in Washington State Am. J. Epidemiol. 98 1973 336 -347
415.
Nery L. E., de Paula A. B., Nakatani J., dos Santos M. L., and Ratto O. R. Clinical, radiological and functional pulmonary manifestations in patients with leptospirosis Rev. Inst. Med. Trop. Sao Paulo 19 1977 366 -373
416.
Neves E. d. S., Pereira M. M., Galhardo M. C., Caroli A., Andrade J., Morgado M. G., and Mendes R. P. Leptospirosis patient with AIDS: the first case reported Rev. Soc. Bras. Med. Trop. 27 1994 39 -42
417.
Nicholson G. D., Edwards C. N., Hassell T. A., Everard C. O. R., and Callender J. Urinary diagnostic indices in the management of leptospirosis West Indian Med. J. 38 1989 33 -38
418.
Nicholson V. M. and Prescott J. F. Outer membrane proteins of three pathogenic Leptospira species Vet. Microbiol. 36 1993 123 -138
419.
Nicodemo A. C., Duarte M. I. S., Alves V. A. F., Takakura C. F. H., Santos R. T. M., and Nicodemo E. L. Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia Am. J. Trop. Med. Hyg. 56 1997 181 -187
420.
Nicolescu M. and Andreescu N. May human leptospirosis develop as a chronic infection? Zentbl. Bakteriol. 257 1984 531 -534
421.
Nie D. K., Wu S. H., Shi M. H., Lu M. L., Jiang S. X., Zhu G. F., Wang H. Q., and Liu Y. M. Studies on endotoxin of Leptospira. I. Extraction of lipopolysaccharides from Leptospira interrogans serovar Lai and analysis of their chemical and biological properties Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao 6 1984 321 -325
422.
O'Brien M. M., Vincent J. M., Person D. A., and Cook B. A. Leptospirosis and acute pancreatitis: a report of ten cases Pediatr. Infect. Dis. J. 17 1998 436 -438
423.
Oie S., Hironaga K., Koshiro A., Konishi H., and Yoshii Z. In vitro susceptibilities of five Leptospira strains to 16 antimicrobial agents Antimicrob. Agents Chemother. 24 1983 905 -908
424.
Oliveira M. A. A., Caballero O. L., Dias Neto E., Koury M. C., Romanha A. J., Carvalho J., Hartskeerl R. A., and Simpson A. J. G. Use of nondenaturing silver-stained polyacrylamide gel analysis of polymerase chain reaction amplification products for the differential diagnosis of Leptospira interrogans infection Diagn. Microbiol. Infect. Dis. 22 1995 343 -348
425.
Oliveira V. J. C., Rocha J. M. B., Silva G. B., and Cabral C. L. N. Observations on a new epidemic outbreak of leptospirosis in greater Recife, Brazil, in 1975 Rev. Inst. Adolfo Lutz 37 1977 33 -36
426.
O'Neill K. M., Rickman L. S., and Lazarus A. A. Pulmonary manifestations of leptospirosis Rev. Infect. Dis. 13 1991 705 -709
427.
Orr H. S. and Little T. W. A. Isolation of leptospira of the serotype hardjo from bovine kidneys Res. Vet. Sci. 27 1979 343 -346
428.
Pacciarini M. L., Savio M. L., Donini G., and Tagliabue S. The search for improved methods for diagnosing leptospirosis: the approach of a laboratory in Brescia, Italy Rev. Sci. Tech. 12 1993 647 -663
429.
Pacciarini M. L., Savio M. L., Tagliabue S., and Rossi C. Repetitive sequences cloned from Leptospira interrogans serovar hardjo genotype hardjoprajitno and their application to serovar identification J. Clin. Microbiol. 30 1992 1243 -1249
430.
Padre L. P., Watt G., Tuazon M. L., Gray M. R., and Laughlin L. W. A serologic survey of rice-field leptospirosis in central Luzon, Philippines Southeast Asian J. Trop. Med. Public Health 19 1988 197 -199
431.
Palit A. and Gulasekharam J. Genus-specific leptospiral antigen and its possible use in laboratory diagnosis J. Clin. Pathol. 26 1973 7 -16
432.
Palit A., Haylock L. M., and Cox J. C. Storage of pathogenic leptospires in liquid nitrogen J. Appl. Bacteriol. 61 1986 407 -411
433.
Palmer M. and Hookey J. The chemiluminescent detection of leptospiral antigen Zentbl. Bakteriol. 277 1992 300 -308
434.
Palmer M., Waitkins S. A., and Zochowski W. Survival of leptospires in commercial blood culture systems Zentbl. Bakteriol. Mikrobiol. Hyg. A 257 1984 480 -487
435.
Palmer M. F., Waitkins S. A., and Wanyangu S. W. A comparison of live and formalised leptospiral microscopic agglutination test Zentbl. Bakteriol. 265 1987 151 -159
436.
Pan American Health Organization Impact of Hurricane Mitch on Central America Epidemiol. Bull. 19 1998 1 -13
437.
Panidis D., Rousso D., Skiadopoulos S., Vavilis D., and Kalogeropoulos A. Hypothalamic-pituitary deficiency after Weil's syndrome: a case report Fertil. Steril. 62 1994 1077 -1079
438.
Pappas M. G., Ballou R., Gray M. R., Takafuji E. T., Miller R. N., and Hockmeyer W. T. Rapid serodiagnosis of leptospirosis using the IgM-specific dot-ELISA: comparison with the microscopic agglutination test Am. J. Trop. Med. Hyg. 34 1985 346 -354
439.
Parenti D. M., Steinberg W., and Kang P. Infectious causes of acute pancreatitis Pancreas 13 1996 256 -371
440.
Park K.-H., Chang W.-H., Lee J.-S., Choi K.-W., Park K.-H., and Oh H.-B. Diagnosis of leptospirosis by enzyme-linked immunosorbent assay J. Korea Soc. Microbiol. 21 1986 181 -189
441.
Park S. H., Ahn B. Y., and Kim M. J. Expression and immunologic characterization of recombinant heat shock protein 58 of Leptospira species: a major target antigen of the humoral immune response DNA Cell. Biol. 18 1999 903 -910
442.
Park S.-K., Lee S.-H., Rhee Y.-K., Kang S.-K., Kim K.-J., Kim M.-C., Kim K.-W., and Chang W.-H. Leptospirosis in Chonbuk province of Korea in 1987: a study of 93 patients Am. J. Trop. Med. Hyg. 41 1989 345 -351
443.
Parma A. E., Fernandez A. S., Santisteban C. G., Bowden R. A., and Cerone S. I. Tears and aqueous humor from horses inoculated with Leptospira contain antibodies which bind to cornea Vet. Immunol. Immunopathol. 14 1987 181 -185
444.
Parma A. E., Seijo A., Lucchesi P. M., Deodato B., and Sanz M. E. Differentiation of pathogenic and non-pathogenic leptospires by means of the polymerase chain reaction Rev. Inst. Med. Trop. Sao Paulo 39 1997 203 -207
445.
Parsons M. Electrocardiographic changes in leptospirosis BMJ 2 1965 201 -203
446.
Paster B. J., Dewhirst F. E., Weisburg W. G., Tordoff L. A., Fraser G. J., Hespell R. B., Stanton T. B., Zablen L., Mandelco L., and Woese C. R. Phylogenetic analysis of the spirochetes J. Bacteriol. 173 1991 6101 -6109
447.
Penna D., de Brito T., Pupo A. A., Machado M. M., Galvão P. A. A., and Soares de Almeida S. Kidney biopsy in human leptospirosis Am. J. Trop. Med. Hyg. 12 1963 896 -901
448.
Pereira M. M., Andrade J., Marchevsky R. S., and Ribeiro dos Santos R. Morphological characterization of lung and kidney lesions in C3H/HeJ mice infected with Leptospira interrogans serovar icterohaemorrhagiae: defect of a CD4+ and CD8+ T-cells are prognosticators of the disease progression Exp. Toxicol. Pathol. 50 1998 191 -198
449.
Pereira M. M., Matsuo M. G., Bauab A. R., Vasconcelos S. A., Moraes Z. M., Baranton G., and Saint Girons I. A clonal subpopulation of Leptospira interrogans sensu stricto is the major cause of leptospirosis outbreaks in Brazil J. Clin. Microbiol. 38 2000 450 -452
450.
Pérolat P., Chappel R. J., Adler B., Baranton G., Bulach D. M., Billinghurst M. L., Letocart M., Merien F., and Serrano M. S. Leptospira fainei sp. nov., isolated from pigs in Australia Int. J. Syst. Bacteriol. 48 1998 851 -858
451.
Pérolat P., Grimont F., Regnault B., Grimont P. A. D., Fournié E., Thevenet H., and Baranton G. rRNA gene restriction patterns of Leptospira: a molecular typing system Res. Microbiol. 141 1990 159 -171
452.
Pérolat P., Lecuyer I., Postic D., and Baranton G. Diversity of ribosomal DNA fingerprints of Leptospira serovars provides a database for subtyping and species assignation Res. Microbiol. 144 1993 5 -15
453.
Pérolat P., Merien F., Ellis W. A., and Baranton G. Characterization of Leptospira isolates from serovar hardjo by ribotyping, arbitrarily primed PCR, and mapped restriction site polymorphisms J. Clin. Microbiol. 32 1994 1949 -1957
454.
Perrocheau A. and Pérolat P. Epidemiology of leptospirosis in New Caledonia (South Pacific): a one-year study Eur. J. Epidemiol. 13 1997 161 -167
455.
Petchclai B., Hiranras S., and Potha U. Gold immunoblot analysis of IgM-specific antibody in the diagnosis of human leptospirosis Am. J. Trop. Med. Hyg. 45 1991 672 -675
456.
Peter G. Leptospirosis: a zoonosis of protean manifestations Pediatr. Infect. Dis. J. 1 1982 282 -288
457.
Petzetakis M. A propos d'une épidémie de spirochétose ictérohémmorragique à l'ile de Syra: origine hydrique del'épidémie, presence des spirochètes chez les rats d'égout, en Grèce Bull. Soc. Pathol. Exot. 25 1932 411 -416
458.
Phillip N. A. Leptospirosis: New Zealand's no. 1 dairy occupational disease N. Z. Vet. J. 24 1976 6 -8
459.
Pierce P. F., Utz J. P., and Lack E. E. Leptospirosis Pathology of infectious diseases Connor D. H., Chandler F. W., Schwartz D. A., Manz H. J., and Lack E. E. 1 1997 615 -619 Appleton & Lange Stamford, Conn
460.
Pike R. M. Laboratory-associated infections: summary and analysis of 3921 cases Health Lab. Sci. 13 1976 105 -114
461.
Poh S. C. and Soh C. S. Lung manifestations in leptospirosis Thorax 25 1970 751 -755
462.
Postic D., Riquelme-Sertour N., Merien F., Pérolat P., and Baranton G. Interest of partial 16S rDNA gene sequences to resolve heterogeneities between Leptospira collections: application to L. meyeri Res. Microbiol. 151 2000 333 -341
463.
Pot A. W. and Dornickx C. G. T. The complement fixation test in the diagnosis of Weil's disease J. Pathol. Bacteriol. 43 1936 367 -372
464.
Prescott J. F., Ferrier R. L., Nicholson V. M., Johnston K. M., and Hoff B. Is canine leptospirosis underdiagnosed in southern Ontario? A case report and serological survey Can. Vet. J. 32 1991 481 -486
465.
Prescott J. F., Miller R. B., and Nicholson V. M. Isolation of Leptospira hardjo from kidneys of Ontario cattle at slaughter Can. J. Vet. Res. 51 1987 229 -231
466.
Prescott J. F., Miller R. B., Nicholson V. M., Martin S. W., and Lesnick T. Seroprevalence and association with abortion of leptospirosis in cattle in Ontario Can. J. Vet. Res. 52 1988 210 -215
467.
Rajiv C., Manjuran R. J., Sudhayakumar N., and Haneef M. Cardiovascular involvement in leptospirosis Indian Heart J. 48 1996 691 -694
468.
Ralph D. and McClelland M. Phylogenetic evidence for horizontal transfer of an intervening sequence between species in a spirochete genus J. Bacteriol. 176 1994 5982 -5987
469.
Ralph D., McClelland M., Welsh J., Baranton G., and Perolat P. Leptospira species categorized by arbitrarily primed polymerase chain reaction (PCR) and by mapped restriction polymorphisms in PCR-amplified rRNA genes J. Bacteriol. 175 1993 973 -981
470.
Ram P. and Chandra M. S. Unusual electrocardiographic abnormality in leptospirosis: case reports J. Vasc. Dis. 36 1985 477 -482
471.
Ramachandran S. Electrocardiographic abnormalities in leptospirosis J. Trop. Med. Hyg. 78 1975 210 -213
472.
Ramachandran S. and Perera M. V. F. Cardiac and pulmonary involvement in leptospirosis Trans. R. Soc. Trop. Med. Hyg. 71 1977 56 -59
473.
Ramachandran S., Rajapakse C. N. A., Perera M. V. F., and Yoganathan M. Patterns of acute renal failure in leptospirosis J. Trop. Med. Hyg. 79 1976 158 -160
474.
Ramadass P., Jarvis B. D. W., Corner R. J., Cinco M., and Marshall R. B. DNA relatedness among strains of Leptospira biflexa Int. J. Syst. Bacteriol. 40 1990 231 -235
475.
Ramadass P., Jarvis B. D. W., Corner R. J., Penny D., and Marshall R. B. Genetic characterization of pathogenic Leptospira species by DNA hybridization Int. J. Syst. Bacteriol. 42 1992 215 -219
476.
Ramos-Morales F., Dı́az-Rivera R. S., Cintrón-Rivera A. A., Rullán J. A., Benenson A. S., and Acosta-Matienzo J. The pathogenesis of leptospiral jaundice Ann. Intern. Med. 51 1959 861 -878
477.
Rathinam S. R., Rathnam S., Selvaraj S., Dean D., Nozik R. A., and Namperumalsamy P. Uveitis associated with an epidemic outbreak of leptospirosis Am. J. Ophthalmol. 124 1997 71 -79
478.
Rathinam S., Ratnam S., Sureshbabu L., and Natarajaseenivasan K. Leptospiral antibodies in patients with recurrent ophthalmic involvement Indian J. Med. Res. 103 1996 66 -68
479.
Ratnam S. Leptospirosis: an Indian perspective Indian J. Med. Microbiol. 12 1994 228 -239
480.
Ratnam S., Sundararaj T., Subramanian S., Madanagopalan N., and Jayanthi V. Humoral and cell-mediated immune responses to leptospires in different human cases Trans. R. Soc. Trop. Med. Hyg. 78 1984 539 -542
481.
Redstone J. S. and Woodward M. J. The development of a ligase mediated PCR with potential for differentiation of serovars within Leptospira interrogans Vet. Microbiol. 51 1996 351 -362
482.
Reisberg B. E., Wurtz R., Diaz P., Francis B., Zakowski P., Fannin S., Sesline D., Waterman S., Sanderson R., McChesney T., Boddie R., Levy M., Miller G., and Herrera G. Outbreak of leptospirosis among white-water rafters— Costa Rica, 1996 Morb. Mortal. Wkly. Rep. 46 1997 577 -579
483.
Renesto P., Lorvellec-Guillon K., Drancourt M., and Raoult D. rpoB gene analysis as a novel strategy for identification of spirochetes from the genera Borrelia, Treponema, and Leptospira J. Clin. Microbiol. 38 2000 2200 -2203
484.
Ribeiro M. A., Assis C. S. N., and Romero E. C. Serodiagnosis of human leptospirosis employing immunodominant antigen Serodiagn. Immunother. Infect. Dis. 6 1994 140 -144
485.
Ribeiro M. A., Souza C. C., and Almeida S. H. P. Dot-ELISA for human leptospirosis employing immunodominant antigen J. Trop. Med. Hyg. 98 1995 452 -456
486.
Richaud C., Margarita D., Baranton G., and Saint Girons I. Cloning of genes required for amino acid biosynthesis from Leptospira interrogans serovar icterohaemorrhagiae J. Gen. Microbiol. 136 1990 651 -656
487.
Rittenberg M. B., Linscott W. D., and Ball M. G. Simple method for separating leptospirae from contaminating microorganisms J. Bacteriol. 76 1958 669 -670
488.
Robertson A. and Boulanger P. Comparison of the complement-fixation test and the microscopic agglutination test (agglutination-lysis) for the detection of leptospiral serogroup antibodies Can. J. Comp. Med. 27 1963 113 -120
489.
Robertson M. H., Clarke I. R., Coghlan J. D., and Gill O. N. Leptospirosis in trout farmers Lancet ii 1981 626 -627
490.
Robinson A. J., Ramadass P., Lee A., and Marshall R. B. Differentiation of subtypes within Leptospira interrogans serovars hardjo, balcanica and tarassovi, by bacterial restriction-endonuclease DNA analysis (BRENDA) J. Med. Microbiol. 15 1982 331 -338
491.
Roch P., Srámková L., and Salák J. The agglutinating and immunofluorescent activities of antileptospiral antibodies of human sera and of immunoglobulins M and G J. Hyg. Epidemiol. Microbiol. Immunol. 20 1976 341 -352
492.
Romero E. C., Billerbeck A. E. C., Lando V. S., Camargo E. D., Souza C. C., and Yasuda P. H. Detection of Leptospira DNA in patients with aseptic meningitis by PCR J. Clin. Microbiol. 36 1998 1453 -1455
493.
Romero E. C., Caly C. R., and Yasuda P. H. The persistence of leptospiral agglutinins titers in human sera diagnosed by the microscopic agglutination test Rev. Inst. Med. Trop. Sao Paulo 40 1998 183 -184
494.
Roth E. E., Linder D., and Adams W. V. The use of agar plates as an aid for the isolation of leptospires Am. J. Vet. Res. 22 1961 308 -312
495.
Rugman F. P., Pinn G., Palmer M. F., Waite M., and Hay C. R. Anticardiolipin antibodies in leptospirosis J. Clin. Pathol. 44 1991 517 -519
496.
Rule P. L. and Alexander A. D. Gellan gum as a substitute for agar in leptospiral media J. Clin. Microbiol. 23 1986 500 -504
497.
Russell R. W. R. Treatment of leptospirosis with oxytetracycline Lancet ii 1958 1143 -1145
498.
Saint Girons I., Bourhy P., Ottone C., Picardeau M., Yelton D., Hendrix R. W., Glaser P., and Charon N. The LE1 bacteriophage replicates as a plasmid within Leptospira biflexa: construction of an L. biflexa-Escherichia coli shuttle vector J. Bacteriol. 182 2000 5700 -5705
499.
Sakamoto N., Yanagawa R., Ono E., Kida H., Mori M., Arimitsu Y., Akama K., Yasuda J., and Too K. Detection of antibodies to leptospiral genus-specific antigen in human and animal sera by indirect hemagglutination test with a partially purified genus-specific protein antigen Zentbl. Bakteriol. 259 1985 548 -556
References 501 through 681 have been omitted.

Information & Contributors

Information

Published In

cover image Clinical Microbiology Reviews
Clinical Microbiology Reviews
Volume 14Number 21 April 2001
Pages: 296 - 326
PubMed: 11292640

History

Published online: 1 April 2001

Permissions

Request permissions for this article.

Contributors

Author

Paul N. Levett
University of the West Indies, School of Clinical Medicine & Research, and Leptospira Laboratory, Ministry of Health, Barbados

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy